AI assistant
Altek — Interim / Quarterly Report 2021
Nov 16, 2021
52290_rns_2021-11-16_e92a4c56-29c6-433c-9cd3-e5a0a1b01b98.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED FINANCIAL STATEMENTS AND
INDEPENDENT AUDITORS’ REVIEW REPORT
SEPTEMBER 30, 2021 AND 2020 (Stock Code : 3059)
~1~
INDEPENDENT AUDITORS’ REVIEW REPORT TRANSLATED FROM CHINESE
PWCR 21000111 (In Thousands of New Taiwan Dollars)
To Altek Corporation
Introduction
We have reviewed the accompanying consolidated balance sheets of Altek Corporation and subsidiaries as at September 30, 2021 and 2020, and the related consolidated statements of comprehensive income for the three-month and nine-month periods then ended, as well as the consolidated statements of changes in equity and of cash flows for the nine-month periods then ended, and notes to the consolidated financial statements, including a summary of significant accounting policies. Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34 “Interim Financial Reporting” as endorsed by Financial Supervisory Commission. Our responsibility is to express a conclusion on these consolidated financial statements based on our reviews.
Scope of review
Except as explained in the following paragraph, we conducted our reviews in accordance with the Statement of Auditing Standards No. 65, “Review of Financial Information Performed by the Independent Auditor of the Entity” in the Republic of China. A review of consolidated financial statements consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Basis for qualified conclusion
As explained in Note 4(3), the financial statements of certain insignificant consolidated subsidiaries and the information disclosed in Note 13 were based solely on the reports prepared by those subsidiaries which were not reviewed by independent auditors. Those statements reflect total assets of $2,484,761 and $2,524,641, constituting 16% and 18% of the consolidated total assets, and total liabilities of $52,632 and $31,490, constituting 1% and 1% of the consolidated total liabilities as at September 30, 2021 and
~2~
2020, respectively, and total comprehensive income of $2,245, $78,443, $24,631 and $65,164, constituting 2%, 92%, 20% and 442% of the consolidated total comprehensive income for the threemonth and nine-month periods then ended, respectively.
Qualified Conclusion
Except for the adjustments to the consolidated financial statements, if any, as might have been determined to be necessary had the financial statements of certain insignificant consolidated subsidiaries been reviewed by independent auditors, as described in the Basis for qualified conclusion section, based on our reviews, nothing has come to our attention that causes us to believe that the accompanying consolidated financial statements do not present fairly, in all material respects, the consolidated financial position of the Group as at September 30, 2021 and 2020, and of its consolidated financial performance for the three-month and nine-month periods then ended and its consolidated cash flows for the ninemonth periods then ended in accordance with Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Accounting Standard 34, “Interim Financial Reporting” as endorsed by the Financial Supervisory Commission.
Li, Tien-Yi Chiang, Tsai-Yen For and on behalf of PricewaterhouseCoopers, Taiwan
November 2, 2021
The accompanying consolidated financial statements are not intended to present the financial position and results of operations and cash flows in accordance with accounting principles generally accepted in countries and jurisdictions other than the Republic of China. The standards, procedures and practices in the Republic of China governing the audit of such financial statements may differ from those generally accepted in countries and jurisdictions other than the Republic of China. Accordingly, the accompanying consolidated financial statements and report of independent auditors’ review report are not intended for use by those who are not informed about the accounting principles or auditing standards generally accepted in the Republic of China, and their applications in practice.
As the financial statements are the responsibility of the management, PricewaterhouseCoopers cannot accept any liability for the use of, or reliance on, the English translation or for any errors or misunderstandings that may derive from the translation.
~3~
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
SEPTEMBER 30, 2021, DECEMBER 31, 2020 AND SEPTEMBER 30, 2020 (Expressed in thousands of New Taiwan dollars)
(The balance sheets as of September 30, 2021 and 2020 are reviewed, not audited)
==> picture [521 x 564] intentionally omitted <==
----- Start of picture text -----
September 30, 2021 December 31, 2020 September 30, 2020
Assets Notes AMOUNT % AMOUNT % AMOUNT %
Current assets
1100 Cash and cash equivalents 6(1) $ 5,438,633 34 $ 5,373,406 37 $ 5,813,248 41
1110 Current financial assets at fair 6(2)
value through profit or loss - - 349,664 2 - -
1136 Current financial assets at 6(4)
amortised cost 128,828 1 423,387 3 414,487 3
1140 Current contract assets - - 4,414 - 4,415 -
1170 Accounts receivable, net 6(5) 1,731,226 11 1,273,383 9 1,042,950 7
1200 Other receivables 102,906 1 68,825 - 54,746 -
1220 Current income tax assets 4,052 - 3,292 - 3,733 -
130X Inventories, net 6(6) 1,854,735 12 1,106,726 8 960,398 7
1410 Prepayments 306,088 2 217,600 1 181,069 1
1470 Other current assets 9,879 - 4,535 - 9,498 -
11XX Current Assets 9,576,347 61 8,825,232 60 8,484,544 59
Non-current assets
1510 Non-current financial assets at 6(2)
- - -
fair value through profit or loss 68,441 48,229 48,076
1517 Non-current financial assets at 6(3)
fair value through other
comprehensive income 122,693 1 43,130 - 45,544 -
1535 Non-current financial assets at 6(4)
amortised cost 1,288,708 8 1,419,002 10 1,389,174 10
1600 Property, plant and equipment 6(7) and 8 2,640,844 17 2,420,736 17 3,012,621 21
1755 Right-of-use assets 6(8) 125,390 1 122,863 1 135,166 1
1760 Investment property 6(9) and 8 1,377,336 9 1,406,586 10 758,620 5
1780 Intangible assets 6(10) 270,593 2 215,261 1 239,295 2
1840 Deferred income tax assets 265,744 1 182,361 1 213,864 2
1900 Other non-current assets 39,860 - 34,746 - 31,170 -
15XX Non-current assets 6,199,609 39 5,892,914 40 5,873,530 41
1XXX Total assets $ 15,775,956 100 $ 14,718,146 100 $ 14,358,074 100
----- End of picture text -----
(Continued)
~4~
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
SEPTEMBER 30, 2021, DECEMBER 31, 2020 AND SEPTEMBER 30, 2020
(Expressed in thousands of New Taiwan dollars)
(The balance sheets as of September 30, 2021 and 2020 are reviewed, not audited)
==> picture [526 x 586] intentionally omitted <==
----- Start of picture text -----
September 30, 2021 December 31, 2020 September 30, 2020
Liabilities and Equity Notes AMOUNT % AMOUNT % AMOUNT %
Current liabilities
2100 Short-term borrowings 6(11) $ 2,510,000 16 $ 2,330,000 16 $ 2,730,000 19
2110 Short-term notes and bills 6(12)
payable 399,939 2 299,798 2 - -
2130 Current contract liabilities 6(21) 147,144 1 32,568 - 92,865 1
2170 Accounts payable 1,747,256 11 1,296,475 9 1,013,430 7
2200 Other payables 607,376 4 485,953 4 548,621 4
2230 Current income tax liabilities 55,052 - 36,763 - 28,157 -
2250 Provisions for liabilities - 6(16)
current 11,497 - 9,295 - 7,955 -
2280 Current lease liabilities 9,721 - 9,336 - 10,279 -
2300 Other current liabilities 6(13) 244,385 2 437,093 3 199,443 1
21XX Current Liabilities 5,732,370 36 4,937,281 34 4,630,750 32
Non-current liabilities
2550 Provisions for liabilities - non- 6(16)
current 166,237 1 160,395 1 156,267 1
2570 Deferred income tax liabilities 513,611 3 464,691 3 498,150 4
2580 Non-current lease liabilities 98,413 1 95,176 1 96,934 1
2600 Other non-current liabilities 33,204 - 36,750 - 39,661 -
25XX Non-current liabilities 811,465 5 757,012 5 791,012 6
2XXX Total Liabilities 6,543,835 41 5,694,293 39 5,421,762 38
Equity attributable to owners of
parent
Share capital 6(17)
3110 Common stock 2,792,659 18 2,794,973 19 2,795,433 19
Capital surplus 6(18)
3200 Capital surplus 2,362,938 15 2,335,226 16 2,333,680 16
Retained earnings 6(19)
3310 Legal reserve 1,418,410 9 1,402,467 9 1,402,467 10
3320 Special reserve 651,556 4 592,325 4 592,325 4
3350 Unappropriated retained
earnings 2,225,468 14 2,249,655 15 2,213,492 15
Other equity interest 6(20)
3400 Other equity interest ( 804,604)( 5)( 697,698)( 5)( 751,761)( 5)
3500 Treasury stocks 6(17) ( 167,127)( 1)( 209,287)( 1)( 209,287)( 1)
31XX Equity attributable to
owners of the parent 8,479,300 54 8,467,661 57 8,376,349 58
36XX Non-controlling interest 4(3) 752,821 5 556,192 4 559,963 4
3XXX Total equity 9,232,121 59 9,023,853 61 8,936,312 62
3X2X Total liabilities and equity $ 15,775,956 100 $ 14,718,146 100 $ 14,358,074 100
----- End of picture text -----
The accompanying notes are an integral part of these consolidated financial statements.
~5~
ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME THREE-MONTH AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2021 AND 2020 (Expressed in thousands of New Taiwan dollars, except earnings per share) (UNAUDITED)
==> picture [525 x 553] intentionally omitted <==
----- Start of picture text -----
Three-month periods ended September 30 Nine-month periods ended September 30
2021 2020 2021 2020
Items Notes AMOUNT % AMOUNT % AMOUNT % AMOUNT %
4000 Operating revenue 6(21) $ 2,470,362 100 $ 1,615,475 100 $ 6,753,566 100 $ 4,252,973 100
5000 Operating costs 6(6)(26)(27) ( 1,814,481) ( 73) ( 1,258,853) ( 78) ( 5,117,556) ( 76) ( 3,230,489) ( 76)
5900 Net operating margin 655,881 27 356,622 22 1,636,010 24 1,022,484 24
Operating expenses 6(26)(27)
6100 Selling expenses ( 11,238) ( 1) ( 10,916) ( 1) ( 35,804) ( 1) ( 40,283) ( 1)
6200 General and administrative
expenses ( 108,181) ( 4) ( 78,441) ( 4) ( 326,959) ( 5) ( 240,200) ( 6)
6300 Research and development
expenses ( 390,312) ( 16) ( 225,046) ( 14) ( 1,049,378) ( 15) ( 656,439) ( 15)
6450 Expected credit gains (losses) 12(2) ( 30) - ( 32) - 61 - 776 -
6000 Total operating expenses ( 509,761) ( 21) ( 314,435) ( 19) ( 1,412,080) ( 21) ( 936,146) ( 22)
6900 Operating profit 146,120 6 42,187 3 223,930 3 86,338 2
Non-operating income and
expenses
7100 Interest income 6(22) 17,582 1 22,738 1 53,958 1 81,806 2
7010 Other income 6(23) 20,895 1 8,454 1 51,266 1 35,490 1
7020 Other gains and losses 6(24) 3,277 - 7,822 - 31,401 - 12,144 -
7050 Finance costs 6(25) ( 6,525) - ( 6,227) - ( 18,989) - ( 18,913) -
7000 Total non-operating income
and expenses 35,229 2 32,787 2 117,636 2 110,527 3
7900 Profit before income tax 181,349 8 74,974 5 341,566 5 196,865 5
7950 Income tax expense 6(28) ( 42,179) ( 2) ( 28,536) ( 2) ( 90,069) ( 1) ( 75,493) ( 2)
8200 Profit for the period $ 139,170 6 $ 46,438 3 $ 251,497 4 $ 121,372 3
----- End of picture text -----
(Continued)
~6~
ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME THREE-MONTH AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2021 AND 2020
(Expressed in thousands of New Taiwan dollars, except earnings per share) (UNAUDITED)
==> picture [525 x 590] intentionally omitted <==
----- Start of picture text -----
Three-month periods ended September 30 Nine-month periods ended September 30
2021 2020 2021 2020
Items Notes AMOUNT % AMOUNT % AMOUNT % AMOUNT %
Other comprehensive income
Components of other
comprehensive income that will
not be reclassified to profit or
loss
8316 Unrealised losses from 6(3)
financial assets measured at
fair value through other
comprehensive income $ 585 - ($ 138) - $ 1,013 - ($ 440) -
8349 Income tax related to 6(28)
components of other
comprehensive income that
will not be reclassified to
profit or loss - - 28 - ( 255) - 88 -
8310 Components of other
comprehensive (loss)
income that will not be
reclassified to profit or loss 585 - ( 110) - 758 - ( 352) -
Components of other
comprehensive income that will
be reclassified to profit or loss
8361 Currency translation
differences of foreign
operations ( 26,239) ( 1) 50,536 3 ( 164,878) ( 2) ( 130,036) ( 3)
8399 Income tax relating to the 6(28)
components of other
comprehensive income 5,145 - ( 11,249) ( 1) 34,071 - 23,744 -
8360 Components of other
comprehensive income
(loss) that will be
reclassified to profit or loss ( 21,094) ( 1) 39,287 2 ( 130,807) ( 2) ( 106,292) ( 3)
8300 Total other comprehensive
income (loss) for the period ($ 20,509) ( 1) $ 39,177 2 ($ 130,049) ( 2) ($ 106,644) ( 3)
8500 Total comprehensive income for
the period $ 118,661 5 $ 85,615 5 $ 121,448 2 $ 14,728 -
Profit (loss), attributable to:
8610 Owners of the parent $ 94,084 4 $ 41,454 3 $ 186,808 3 $ 123,272 3
8620 Non-controlling interest 45,086 2 4,984 - 64,689 1 ( 1,900) -
Profit for the period $ 139,170 6 $ 46,438 3 $ 251,497 4 $ 121,372 3
Comprehensive (loss) income
attributable to:
8710 Owners of the parent $ 74,088 3 $ 86,336 5 $ 51,281 1 $ 27,944 -
8720 Non-controlling interest 44,573 2 ( 721) - 70,167 1 ( 13,216) -
Total comprehensive income
for the period $ 118,661 5 $ 85,615 5 $ 121,448 2 $ 14,728 -
9750 Basic earnings per share 6(29) $ 0.35 $ 0.16 $ 0.71 $ 0.46
9850 Diluted earnings per share 6(29) $ 0.35 $ 0.16 $ 0.69 $ 0.46
----- End of picture text -----
The accompanying notes are an integral part of these consolidated financial statements.
~7~
ALTEK CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2021 AND 2020
(Expressed in thousands of New Taiwan dollars)
(UNAUDITED)
==> picture [783 x 293] intentionally omitted <==
----- Start of picture text -----
Equity attributable to owners of the parent
Retained earnings Other equity interest
Currency translation
Additional paid-in Unappropriated differences of foreign Non-controlling
Notes Common stock capital Legal reserve Special reserve retained earnings operations Other Treasury stocks Total interest Total equity
Nine-month period ended September 30, 2020
Balance at January 1, 2020 $ 2,753,613 $ 2,280,487 $ 1,394,151 $ 435,679 $ 2,394,976 ($ 494,335 ) ($ 121,024 ) $ - $ 8,643,547 $ 573,179 $ 9,216,726
Profit (loss) for the period - - - - 123,272 - - - 123,272 ( 1,900 ) 121,372
Other comprehensive loss for the period 6(20) - - - - - ( 94,976 ) ( 352 ) - ( 95,328 ) ( 11,316 ) ( 106,644 )
Total comprehensive income (loss) - - - - 123,272 ( 94,976 ) ( 352 ) - 27,944 ( 13,216 ) 14,728
Appropriation of 2019 earnings 6(19)
Legal reserve - - 8,316 - ( 8,316 ) - - - - - -
Special reserve - - - 156,646 ( 156,646 ) - - - - - -
Cash dividends - - - - ( 139,794 ) - - - ( 139,794 ) - ( 139,794 )
Share-based payment transactions 6(15)(20) - - - - - - 53,939 - 53,939 - 53,939
Restricted stocks 6(15)(17)(18)(20) 43,120 54,798 - - - - ( 97,918 ) - - - -
Retirement of employee restricted shares 6(15)(17)(18)(20) ( 1,300 ) ( 1,605 ) - - - - 2,905 - - - -
Treasury shares repurchased - - - - - - - ( 209,287 ) ( 209,287 ) - ( 209,287 )
Balance at September 30, 2020 $ 2,795,433 $ 2,333,680 $ 1,402,467 $ 592,325 $ 2,213,492 ($ 589,311 ) ($ 162,450 ) ($ 209,287 ) $ 8,376,349 $ 559,963 $ 8,936,312
Nine-month period ended September 30,2021
Balance at January 1, 2021 $ 2,794,973 $ 2,335,226 $ 1,402,467 $ 592,325 $ 2,249,655 ($ 550,536 ) ($ 147,162 ) ($ 209,287 ) $ 8,467,661 $ 556,192 $ 9,023,853
Profit for the period - - - - 186,808 - - - 186,808 64,689 251,497
Other comprehensive income (loss) for the 6(20)
period - - - - - ( 136,285 ) 758 - ( 135,527 ) 5,478 ( 130,049 )
Total comprehensive income (loss) - - - - 186,808 ( 136,285 ) 758 - 51,281 70,167 121,448
Appropriation of 2020 earnings 6(19)
Legal reserve - - 15,943 - ( 15,943 ) - - - - - -
Special reserve - - - 59,231 ( 59,231 ) - - - - - -
Cash dividends - - - - ( 134,249 ) - - - ( 134,249 ) - ( 134,249 )
Share-based payment transactions 6(15)(18)(20) - 42,590 - - - - 21,814 - 64,404 - 64,404
Retirement of employee restricted shares 6(15)(17)(18)(20) ( 2,314 ) ( 2,921 ) - - - - 5,235 - - - -
Treasury stock transferred to employees 6(17)(18) - ( 126 ) - - - - - 42,160 42,034 - 42,034
Changes in ownership interests in subsidiaries 6(18) - ( 11,831 ) - - - - - - ( 11,831 ) 11,831 -
Non-controlling interest 6(30) - - - - - - - - - 114,631 114,631
Proceeds from disposal of financial assets at 6(3)(20)
fair value through other comprehensive
income - - - - ( 1,572 ) - 1,572 - - - -
Balance at September 30, 2021 $ 2,792,659 $ 2,362,938 $ 1,418,410 $ 651,556 $ 2,225,468 ($ 686,821 ) ($ 117,783 ) ($ 167,127 ) $ 8,479,300 $ 752,821 $ 9,232,121
----- End of picture text -----
The accompanying notes are an integral part of these consolidated financial statements.
~8~
ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS
NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2021 AND 2020
(Expressed in thousands of New Taiwan dollars) (UNAUDITED)
| CASH FLOWS FROM OPERATING ACTIVITIES Profit before tax Adjustments Adjustments to reconcile profit (loss) Depreciation Amortisation Expected credit gains Net gain on financial assets at fair value through profit or loss Interest expense Interest income Dividend income Share-based payment compensation cost Gain on disposal of property, plant and equipment Changes in operating assets and liabilities Changes in operating assets Current contract assets Accounts receivable Other receivables Inventories Prepayments Other current assets Changes in operating liabilities Current contract liabilities Notes payable Accounts payable Other payables Provisions for liabilities Other current liabilities Other non-current liabilities Cash (outflow) inflow generated from operations Interest received Dividends received Interest paid Income tax paid Net cash flows (used in) from operating activities |
Nine-month periods ended September 30 Notes 2021 2020 $341,566$196,8656(7)(8)(9)(26) 141,789136,0956(10)(26) 68,89665,48612(2) (61 ) (776 )6(2)(24) (27,931 ) (7,920 )6(25) 18,98918,9136(22) (53,958 ) (81,806 )6(23) (1,526 ) (1,526 )6(15) 64,40453,9396(24) 29-4,414(4,415 )(459,850 ) (124,316 )(28,030 ) (539 )(769,662 )72,798(90,310 ) (84,919 )(5,413 ) (3,657 )114,66658,786-(4,283 )474,4218,550(7,988 ) (15,576 )8,06021,83457,419(1,310 )3063(150,046 )302,28647,91769,4981,5261,526(16,182 ) (17,230 )(73,059 ) (65,533 )(189,844 )290,547 |
|---|---|
(Continued)
~9~
ALTEK CORPORATION AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS
NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2021 AND 2020
(Expressed in thousands of New Taiwan dollars) (UNAUDITED)
| CASH FLOWS FROM INVESTING ACTIVITIES Acquisition of financial assets at fair value through profit or loss Proceeds from disposal of financial assets at fair value through profit or less Acquisition of financial assets at amortised cost Proceeds from repayments of financial assets at amortised cost Acquisition of financial assets at fair value through other comprehensive income Proceeds from disposal of financial assets at fair value through other comprehensive income Proceeds from capital reduction of financial assets at fair value through other comprehensive income Acquisition of property, plant and equipment Proceeds from disposal of property, plant and equipment Acquisition of intangible assets (Increase) decrease in deposits paid Net cash flows from (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from short-term borrowings Repayment of short-term borrowings Proceeds from issuance of short-term notes and bills payable Repayment of short-term notes and bills payable Repayment of long-term borrowings (Decrease) increase in guarantee deposits received Repayment of principal portion of lease liabilities Acquisition of treasury stocks Treasury shares transferred to employees Changes in non-controlling interest Net cash flows from financing activities Effect of exchange rate Net increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period |
Nine-month periods ended September 30 Notes 2021 2020 ($151,406 )$-505,671--(1,081,722 )397,98213,385(86,694 )-2,325-3,0564,3646(31) (355,334 ) (11,796 )428-6(31) (125,512 ) (54,883 )(5,197)9,222185,319(1,121,430)6(32) 11,650,00012,330,0006(32) (11,470,000 ) (11,800,000 )6(32) 1,698,274459,5176(32) (1,600,000 ) (690,000 )6(32) (250,000 )-(3,279 )10,2626(32) (10,636 ) (6,596 )6(17) -(209,287 )42,034-114,631-171,02493,896(101,272) (115,820)65,227(852,807 )6(1) 5,373,4066,666,0556(1) $5,438,633$5,813,248 |
|---|---|
The accompanying notes are an integral part of these consolidated financial statements.
~10~
ALTEK CORPORATION AND SUBSIDIARIES
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2021 AND 2020
(Expressed in thousands of New Taiwan dollars, except as otherwise indicated)
(Reviewed, not audited)
1. HISTORY AND ORGANIZATION
Altek Corporation (the “Company”) was incorporated as a company limited by shares under the provisions of the Company Law of the Republic of China (R.O.C.). The Company and its subsidiaries (collectively referred herein as the “Group”) are primarily engaged in the development, manufacturing and sale of digital image technology application, and related export and import trade.
The Company was listed in the Taiwan Stock Exchange on December 24, 2002, as approved by the TaiTz (91) Letter No. 024976 of the former Securities and Futures Commission, Ministry of Finance, R.O.C., dated September 27, 2002.
2. THE DATE OF AUTHORISATION FOR ISSUANCE OF THE CONSOLIDATED FINANCIAL STATEMENTS AND PROCEDURES FOR AUTHORISATION
These consolidated financial statements were reported to the Board of Directors and issued on November 2, 2021.
3. APPLICATION OF NEW STANDARDS, AMENDMENTS AND INTERPRETATIONS
- (1) Effect of the adoption of new issuances of or amendments to International Financial Reporting Standards (“IFRSs”) as endorsed by the Financial Supervisory Commission (“FSC”)
New standards, interpretations and amendments endorsed by the FSC effective from 2021 are as follows:
| follows: | |
|---|---|
| New Standards,InterpretationsandAmendments | Effective date by International Accounting StandardsBoard |
| Amendments to IFRS 4, ‘Extension of the temporary exemption from applying IFRS 9’ Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16, ‘Interest Rate Benchmark Reform— Phase 2’ Amendment to IFRS 16, ‘Covid-19-related rent concessions beyond 30 June 2021’ Note:Earlier application from January 1, 2021 is allowed by FSC. |
January 1, 2021 January 1, 2021 April 1, 2021(Note) |
The above standards and interpretations have no significant impact to the Group’s financial condition and financial performance based on the Group’s assessment.
~11~
(2) Effect of new issuances of or amendments to IFRSs as endorsed by the FSC but not yet adopted by
the Group
New standards, interpretations and amendments endorsed by the FSC effective from 2022 are as follows:
| follows: | |
|---|---|
| NewStandards,Interpretations and Amendments Amendments to IFRS 3, ‘Reference to the conceptual framework’ Amendments to IAS 16, ‘Property, plant and equipment:proceeds before intended use’ Amendments to IAS 37, ‘Onerous contracts—cost of fulfilling a contract’ Annual improvements to IFRS Standards 2018–2020 |
Effective date by International Accounting Standards Board |
| January 1, 2022 January 1, 2022 January 1, 2022 January 1, 2022 |
The above standards and interpretations have no significant impact to the Group’s financial condition and financial performance based on the Group’s assessment.
(3) IFRSs issued by IASB but not yet endorsed by the FSC
New standards, interpretations and amendments issued by IASB but not yet included in the IFRSs as endorsed by the FSC are as follows:
| endorsed by the FSC are as follows: | |
|---|---|
| New Standards,InterpretationsandAmendments | Effective date by International Accounting StandardsBoard |
| Amendments to IFRS 10 and IAS 28, ‘Sale or contribution of assets between an investor and its associate or joint venture’ IFRS 17, ‘Insurance contracts’ Amendments to IFRS 17, ‘Insurance contracts’ Amendments to IAS 1, ‘Classification of liabilities as current or non-current’ Amendments to IAS 1, ‘Disclosure of accounting policies’ Amendments to IAS 8, ‘Definition of accounting estimates’ Amendments to IAS 12, ‘Deferred tax related to assets and liabilities arising from a single transaction’ |
To be determined by International Accounting Standards Board January 1, 2023 January 1, 2023 January 1, 2023 January 1, 2023 January 1, 2023 January 1, 2023 |
The above standards and interpretations have no significant impact to the Group’s financial condition and financial performance based on the Group’s assessment.
4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
The principal accounting policies adopted are consistent with Note 4 in the consolidated financial statements for the year ended December 31, 2020, except for the compliance statement, basis of preparation, basis of consolidation and additional policies as set out below. These policies have been consistently applied to all the periods presented, unless otherwise stated.
~12~
(1) Compliance statement
-
A. The consolidated financial statements of the Group have been prepared in accordance with the "Regulations Governing the Preparation of Financial Statements by Securities Issuers" and IAS 34, ‘Interim Financial Reporting’ as endorsed by the FSC.
-
B. The consolidated financial statements should be read together with the 2020 consolidated financial statements.
(2) Basis of preparation
-
A. Except for the following items, the consolidated financial statements have been prepared under the historical cost convention:
-
(a) Financial assets and financial liabilities (including derivative instruments) at fair value through profit or loss.
-
(b) Financial assets at fair value through other comprehensive income.
-
(c) Defined benefit liabilities recognised based on the net amount of pension fund assets less present value of defined benefit obligation.
-
B. The preparation of financial statements in conformity with International Financial Reporting Standards, International Accounting Standards, IFRIC Interpretations, and SIC Interpretations as endorsed by the FSC (collectively referred herein as the “IFRSs”) requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the Group’s accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in Note 5.
(3) Basis of consolidation
-
A. Basis for preparation of consolidated financial statements:
-
Basis for preparation of consolidated financial statements is consistent with the 2020 consolidated financial statements.
-
B. Subsidiaries included in the consolidated financial statements:
(Blank below)
~13~
| Name of Investor | Name of Subsidiaries | Main Business Activities | Ownership (%) | Note | ||
|---|---|---|---|---|---|---|
| September 30, 2021 100 100 100 100 100 100 50 100 100 100 82.18 100 100 100 100 100 75 100 100 100 100 100 100 |
December 31, 2020 100 100 100 100 100 100 50 100 100 100 100 - 100 100 100 100 100 100 100 100 - - - |
September 30, 2020 | ||||
| Altek Corporation " " " Altek International Investment Co., Ltd. " " " " " Altek International Holding (BVI) Co., Ltd. Altek Investment Corporation Note 1 Note 1 Note 1 Note 1 Altek Optical Technology (Cayman) Co., Ltd. Altek Semiconductor (Cayman) Co., Ltd. " Altek Medical Holding (Cayman) Co., Ltd. Altek Medical Holding (Cayman) Co., Ltd. Altek Medical (HongKong) Limited Altek Medical (Shanghai) Limited |
Altek International Investment Co., Ltd. Altek Japan Corporation Altek International Holding (BVI) Co., Ltd. Altek Investment Corporation Altek Lab Inc. Altek Optical (Cayman) Co., Ltd. Altek Semiconductor (Cayman) Co., Ltd. Altek Optical Technology (Cayman) Co., Ltd. Altek Imaging Technology (Cayman) Co., Ltd. Altek International Trading Co., Ltd. Altek Medical Holding (Cayman) Co., Ltd. Ptek Corporation Altek (Kunshan) Co., Ltd. Altek EMS (Kunshan) Co., Ltd. Altek Precision (Kunshan) Co., Ltd. Altek Trading (Shanghai) Limited Altek Optical Technology (Kunshan) Co., Ltd. Altek Semiconductor Corporation Altek Semiconductor (Shanghai) Co., Ltd. Altek Biotechnology Corporation Altek Medical (HongKong) Limited Altek Medical (Shanghai) Limited Altek Medical (Kunshan) Limited |
Investments Sales of optical instruments Investments Investments Design service Investments Investments Investments Investments Intercompany transactions Investments and general business operations Product development and design Manufacture and sales of digital still camera and its accessories Manufacture and sales of related engineering services Manufacture and sales of digital camera parts Wholesale, import and export of related electronic and their associated accessories Manufacture and sales of photo electron device, optical instrument, camera and equipment Research design and sales of ASIC Research design and sales of imaging technologies, electronic software and hardware Research and development, manufacture and sales of medical electronic equipments Investments Sales of medical electronic equipments Manufacture and sales of medical electronic equipments |
100 100 100 100 100 100 50 100 100 100 100 - 100 100 100 100 100 100 100 100 - - - |
- Note 11 Note 10 Note 2 Note 11 Note 11 Note 11 Note 11 Note 11 Note 11 Note 11 Note 3 Note 6 Note 10 Note5 Note13 - Note 11 Note 11 Note 11 Note 4 Note 11 Note 12 Note 11 Note 6 Note 6 Note 7 Note 13 Note 8 Note 13 Note 9 Note 13 |
Note 1: Invested by Leading Tech. Co., Ltd., Toptek Investment Cayman Co., Ltd., Ltd., Altek Trading (Cayman) Co., Ltd., which are wholly owned by Altek International Investment Co., Ltd. Note 2: Invested by Altek Corporation and established on September, 2020.
Note 3: The subsidiary increased its capital, but the Group did not acquire and sell shares of the subsidiary. As a result, the Group’s shareholding ratio decreased since 2021. Note 4: The Group sold 25% of share in Altek Optical Technology (Kunshan) Co., Ltd. on January 6, 2021. As a result, the Group’s shareholding ratio decreased. Note 5: Invested by Altek Investment Corporation and established on April, 2021 and changed its Chinese name on August 11, 2021.
Note 6: Altek Biotechnology Holding (Cayman) Co., Ltd. changed its name to Altek Medical Holding (Cayman) Co., Ltd. since June 8, 2021. Note 7: Invested by Altek Medical Holding (Cayman) Co., Ltd. and established on June, 2021.
Note 8: Invested by Altek Medical (HongKong) Limited and established on August, 2021.
Note 9: Invested by Altek Medical (Shanghai) Limited and established on August, 2021.
Note 10: As the subsidiaries meet the definition of significant subsidiaries, the financial statements as of September 30, 2021 were reviewed by independent auditors.
As the subsidiaries did not meet the definition of significant subsidiaries, the financial statements as of September 30, 2020 were not reviewed by independent auditors.
Note 11: For these non-significant subsidiaries, the financial statements as of September 30, 2021 and 2020 were not reviewed by independent auditors. Note 12: For these non-significant subsidiaries, the financial statements as of September 30, 2021 and 2020 were reviewed by independent auditors. Note 13: For these non-significant subsidiaries, the financial statements as of September 30, 2021 were not reviewed by independent auditors.
~14~
-
C. Subsidiaries not included in the consolidated financial statements: None.
-
D. Adjustments for subsidiaries with different balance sheet dates: None.
-
E. Significant restrictions: None.
-
F. Subsidiaries that have non-controlling interests that are material to the Group:
-
As of September 30, 2021, December 31, 2020, and September 30, 2020, the non-controlling interest amounted to $752,821, $556,192 and $559,963, respectively. The information of noncontrolling interest and respective subsidiaries is as follows:
Non-controlling interest
| Name of subsidiary |
Principal place of business Republic of China Republic of China China |
Amount Ownership (%) $581,285 50 143,711 17.82 27,825 25 September 30,2021 |
Amount Ownership (%) $556,192 50 - - - - December 31,2020 |
Amount Ownership (%) $559,963 50 - - - - September 30,2020 |
Description |
|---|---|---|---|---|---|
| Amount $581,285 143,711 27,825 |
Amount $556,192 - - |
Amount $559,963 - - |
|||
| Altek Semiconductor (Cayman) Co. , Ltd. Altek Medical Holding (Cayman) Co. , Ltd. Altek Optical Technology (Kunshan) Co. , Ltd. |
Note Note |
Note : The country of registration is Cayman Islands.
Summarised financial information of the subsidiaries: Balance sheets
| Balance sheets | ||
|---|---|---|
| Current assets Non-current assets Current liabilities Non-current liabilities Total net assets Current assets Non-current assets Current liabilities Non-current liabilities Total net assets |
September 30,2021 December 31,2020 September 30,2020 1,282,556 $ 1,131,058 $ 1,138,287 $ 252,362 179,042 204,908 372,300) ( 197,580) ( 222,676) ( 47) ( 135) ( 594) ( 1,162,571 $ 1,112,385 $ 1,119,925 $ Altek Semiconductor(Cayman)Co.,Ltd. Altek Medical Holding (Cayman)Co.,Ltd. Altek Optical Technology (Kunshan)Co.,Ltd. September 30,2021 September 30,2021 1,703,706 $ 121,781 $ 41,061 68,706 816,865) ( 79,188) ( 121,445) ( - 806,457 $ 111,299 $ |
|
| September 30,2021 | ||
| 1,703,706 $ 41,061 816,865) ( 121,445) ( 806,457 $ |
~15~
Statements of comprehensive income
| Revenue Profit before income tax Income tax expense Profit for the period Other comprehensive loss, net of tax Total comprehensive income (loss) for the period Revenue Profit (loss) before income tax Income tax benefit (expense) Profit for the period Other comprehensive loss, net of tax Total comprehensive income for the period Revenue Profit before income tax Income tax expense Profit for the period Other comprehensive (loss) income, net of tax Total comprehensive income for the period |
Altek Semiconductor | Altek Semiconductor | (Cayman)Co.,Ltd. | |
|---|---|---|---|---|
| For the three-month period ended September 30,2021 |
For the three-month period ended September 30,2020 |
|||
| ( ( |
312,261 $ 71,342 3,533) 67,809 732) 67,077 $ For the nine-month period endedSeptember 30,2021 |
( | 139,443 $ 10,521 554) ( 9,967 11,410) ( 1,443) $ For the nine-month period endedSeptember 30,2020 |
|
| ( | ||||
| For the three-month period endedSeptember 30,2021 |
For the nine-month period endedSeptember 30,2021 |
|||
| 705,929 $ 64,762 13,850) ( 50,912 123) ( 50,789 $ |
2,152,046 $ 201,794 44,158) ( 157,636 24,086 181,722 $ |
~16~
Altek Optical Technology (Kunshan) Co. , Ltd.
| Revenue Profit before income tax Income tax expense Profit for the period Other comprehensive loss, net of tax Total comprehensive income for the period |
For the three-month period ended September 30,2021 |
For the nine-month period ended September 30,2021 |
||
|---|---|---|---|---|
| 73,003 $ 8,393 - 8,393 457) ( 7,936 $ |
169,288 $ 27,970 - 27,970 4,506) ( 23,464 $ |
(4) Employee benefits
Pension-Defined benefit plans
Pension cost for the interim period is calculated on a year-to-date basis by using the pension cost rate derived from the actuarial valuation at the end of the prior financial year, adjusted for significant market fluctuations since that time and for significant curtailments, settlements, or other significant one-off events. And, the related information is disclosed accordingly.
(5) Income tax
-
A. The interim period income tax expense is recognised based on the estimated average annual effective income tax rate expected for the full financial year applied to the pretax income of the interim period, and the related information is disclosed accordingly.
-
B. If a change in tax rate is enacted or substantively enacted in an interim period, the Group recognises the effect of the change immediately in the interim period in which the change occurs. The effect of the change on items recognised outside profit or loss is recognised in other comprehensive income or equity while the effect of the change on items recognized in profit or loss is recognised in profit or loss.
5. Critical Accounting Judgements, Estimates and Key Sources of Assumption Uncertainty
There have been no significant changes as of September 30, 2021. Please refer to Note 5 in the consolidated financial statements for the year ended December 31, 2020.
6. DETAILS OF SIGNIFICANT ACCOUNTS
(1) Cash and cash equivalents
| Cash on hand revolving funds Checking accounts and demand deposits Time deposits Total |
September 30,2021 December 31,2020 938 $ 1,052 $ 1,971,387 1,260,822 3,466,308 4,111,532 5,438,633 $ 5,373,406 $ |
September 30,2020 925 $ 873,044 4,939,279 5,813,248 $ |
|---|---|---|
~17~
-
A. The Group transacts with a variety of financial institutions all with high credit quality to disperse credit risk, so it expects that the probability of counterparty default is remote.
-
B. The Group has no cash and cash equivalents pledged to others.
-
(2) Financial assets at fair value through profit or loss
| Items Current items: Financial assets mandatorily measured at fair value through profit or loss Structured deposits Valuation adjustment Total Non-current items: Financial assets mandatorily measured at fair value through profit or loss Unlisted stocks Valuation adjustment Total |
September 30,2021 December 31,2020 - $ 349,186 $ - 478 - $ 349,664 $ 10,312 $ 10,312 $ 58,129 37,917 68,441 $ 48,229 $ |
September 30,2020 - $ - - $ 10,312 $ 37,764 48,076 $ |
|---|---|---|
- A. Amounts recognised in profit or loss in relation to financial assets at fair value through profit or loss are listed below:
| loss are listed below: | |
|---|---|
| For the three-month period ended September 30,2021 Equity instruments 1,243) ($ Structured deposit 1,550 Total 307 $ For the nine-month period ended September 30,2021 Equity instruments 20,212 $ Structured deposit 7,719 Total 27,931 $ |
For the three-month period ended September 30,2020 |
| 6,409 $ - |
|
| 6,409 $ |
|
| For the nine-month period ended September 30,2020 |
|
| 7,920 $ - |
|
| 7,920 $ |
-
B. The Group has no financial assets at fair value through profit or loss pledged to others as at September 30, 2021, December 31, 2020, and September 30, 2020.
-
C. Information relating to credit risk of financial assets at fair value through profit or loss is provided in Note 12(2).
~18~
(3) Financial assets at fair value through other comprehensive income
| Items Non-current items: Equity instruments Unlisted stocks Valuation adjustment ( Total |
September 30,2021 December 31,2020 221,383 $ 144,405 $ 98,690) 101,275) ( ( 122,693 $ 43,130 $ |
September 30,2020 143,472 $ 97,928) 45,544 $ |
|---|---|---|
-
A. The Group has elected to classify equity instruments that are considered to be strategic investments as financial assets at fair value through other comprehensive income. The fair value of such investments amounted to $122,693, $43,130 and $45,544 as at September 30, 2021, December 31, 2020, and September 30, 2020, respectively.
-
B. Amounts recognised in profit or loss and other comprehensive income in relation to the financial assets at fair value through other comprehensive income amounted to $585, ($138), $1,013 and ($440) for the three-month and nine-month periods ended September 30, 2021 and 2020, respectively. For the three-month and nine-month periods ended September 30, 2021, the accumulated loss due to delisting and transferring returned surplus was $0 and $1,572, respectively.
-
C. The Group has no financial assets at fair value through profit or loss as at September 30, 2021, December 31, 2020, and September 30, 2020 pledged to others.
(4) Financial assets at amortised cost
| Items Current items: Time deposit with maturity from three months to one year Non-current items: Time deposit with maturity over one year |
September 30,2021 December 31,2020 128,828 $ 423,387 $ 1,288,708 $ 1,419,002 $ |
September 30,2020 414,487 $ 1,389,174 $ |
|---|---|---|
- A. Amounts recognised in profit or loss in relation to financial assets at amortised cost are listed below:
| below: | ||
|---|---|---|
| Interest income Interest income |
For the three-month period ended September30,2021 11,042 $ For the nine-month period ended September 30,2021 34,635 $ |
For the three-month period ended September30,2020 |
| 13,296 $ |
||
| For the nine-month period ended September 30,2020 |
||
| 32,874 $ |
-
B. The Group has no financial assets at amortised cost pledged to others.
-
C. Information relating to credit risk of financial assets at amortised cost is provided in Note 12(2).
~19~
(5) Accounts receivable
| A. The ageing analysis of accounts Accounts receivable Less: Allowance for uncollectible accounts Not past due Up to 30 days 31 to 90 days |
receivable that was past due but not impaired is as follows: September 30,2021 December 31,2020 September 30,2020 1,731,430 $ 1,273,648 $ 1,043,170 $ 204) ( 265) ( 220) ( 1,731,226 $ 1,273,383 $ 1,042,950 $ September 30,2021 December 31,2020 September 30,2020 1,555,582 $ 1,257,413 $ 1,026,763 $ 175,549 8,351 16,206 299 7,884 201 1,731,430 $ 1,273,648 $ 1,043,170 $ |
|---|---|
A. The ageing analysis of accounts receivable that was past due but not impaired is as follows:
The above ageing analysis was based on past due date.
-
B. As of September 30, 2021, December 31, 2020, and September 30, 2020, accounts receivable were all from contracts with customers. And as of January 1, 2020, the balance of accounts receivable and notes receivable from contracts with customers amounted to $918,019.
-
C. The Group’s accounts receivable do not hold any collateral provided by customers.
-
D. As at September 30, 2021, December 31, 2020, and September 30, 2020, without taking into account any collateral held or other credit enhancements, the maximum exposure to credit risk in respect of the amount that best represents the Group’s notes and accounts receivable was $1,731,226, $1,273,383 and $1,042,950, respectively.
-
E. Information relating to credit risk of accounts receivable is provided in Note 12(2).
(6) Inventories
| Inventories | ||||||
|---|---|---|---|---|---|---|
| Raw materials Work in progress Finished goods Total Raw materials Work in progress Finished goods Total |
Cost 1,399,893 $ 332,439 177,735 1,910,067 $ |
September 30,2021 | ||||
| Allowance for valuation loss 21,615) ($ 25,328) ( 8,389) ( 55,332) ($ December31,2020 |
Book value | |||||
| 1,378,278 $ 307,111 169,346 |
||||||
| 1,854,735 $ |
||||||
| December31,2020 | ||||||
| Cost 771,902 $ 165,380 208,592 1,145,874 $ |
~20~
| Raw materials Work in progress Finished goods Total |
September30,2020 | ||
|---|---|---|---|
| Cost 580,534 $ 208,135 198,513 987,182 $ |
Allowance for valuation loss 17,580) ($ 1,215) ( 7,989) ( 26,784) ($ |
Bookvalue | |
| 562,954 $ 206,920 190,524 |
|||
| 960,398 $ |
The cost of inventories recognised as expense for the period:
| Cost of goods sold and others Loss (gain on reversal of) decline in market value Total Cost of goods sold and others Loss(gain on reversal of) decline in market value Total |
For the three-month period ended September 30,2021 1,796,923 $ 17,558 1,814,481 $ For the nine-month period ended September 30,2021 5,101,372 $ 16,184 5,117,556 $ |
For the three-month period ended September 30,2020 1,272,079 $ 13,226) ( 1,258,853 $ For the nine-month period ended September 30,2020 3,258,781 $ 28,292) ( 3,230,489 $ |
|---|---|---|
For the three-month and nine-month periods ended September 30, 2020, the Group reversed a previous inventory write-down and accounted for as reduction of cost of goods sold because inventory that has been appropriated as loss on decline in market value was partially sold.
~21~
(7) Property, plant and equipment
| At January 1 Cost Accumulated depreciation Opening net book amount Additions Disposals Reclassifications Depreciation charge Net exchange differences Closing net book amount At September 30 Cost Accumulated depreciation |
2021 | ||||
|---|---|---|---|---|---|
~22~
| At January 1 Cost Accumulated depreciation Opening net book amount Additions Reclassifications Depreciation charge Net exchange differences Closing net book amount At September 30 Cost Accumulated depreciation |
2020 | |||
|---|---|---|---|---|
-
A. For the nine-month periods ended September 30, 2021 and 2020, there was no capitalisation of borrowing interests attributable to the property, plant and equipment.
-
B. Information about the property, plant and equipment that were pledged to others as collaterals is provided in Note 8.
~23~
- (8) Leasing arrangements lessee
-
A. The Group leases various assets including land, buildings, and business vehicles. Rental contracts are typically made for periods of 1 to 49 years. Lease terms are negotiated on an individual basis and contain a wide range of different terms and conditions. The lease agreements do not impose covenants, but leased assets may not be used as security for borrowing purposes.
-
B. Short-term leases with a lease term of 12 months or less comprise of buildings and equipment. Low-value assets comprise of printers.
-
C. The carrying amount of the depreciation charge are as follows:
| Carryingamount | Carryingamount | Carryingamount | |||||||
|---|---|---|---|---|---|---|---|---|---|
| September | 30,2021 | December31,2020 | September30,2020 | ||||||
| Land | $ | 107,362 |
$ | 110,455 |
$ | 120,716 |
|||
| Buildings | 11,200 | 1,421 | 1,854 | ||||||
| Transportation equipment | |||||||||
| (Business vehicles) | 6,828 | 10,987 | 12,596 | ||||||
| $ | 125,390 |
$ | 122,863 |
$ | 135,166 |
||||
| Depreciation | charge | ||||||||
| For the three-month | For the three-month | ||||||||
| period ended | period | ended | |||||||
| September 30,2021 | September 30,2020 | ||||||||
| Land | $ | 928 |
$ | 998 |
|||||
| Buildings | 1,307 | 462 | |||||||
| Transportation equipment (Business vehicles) | 1,208 | 1,035 | |||||||
| $ | 3,443 |
$ | 2,495 |
||||||
| Depreciation | charge | ||||||||
| For the nine-month | For the nine-month | ||||||||
| period ended | period | ended | |||||||
| September 30,2021 | September 30,2020 | ||||||||
| Land | $ | 2,784 |
$ | 2,996 |
|||||
| Buildings | 3,648 | 1,234 | |||||||
| Transportation equipment (Business vehicles) | 4,159 | 2,533 | |||||||
| $ | 10,591 |
$ | 6,763 |
- D. For the three-month and nine-month periods ended September 30, 2021 and 2020, the additions to right-of-use assets were $0, $10,325, $13,440 and $10,325, respectively.
~24~
E. The information on profit and loss accounts relating to lease contracts is as follows:
| Items affecting profit or loss Interest expense on lease liabilities Expense on short-term lease contracts Expense on leases of low-value assets Items affecting profit or loss Interest expense on lease liabilities Expense on short-term lease contracts Expense on leases of low-value assets |
For the three-month period ended September 30,2021 277 $ 1,000 32 For the nine-month period ended September 30,2021 831 $ 4,041 70 |
For the three-month period ended September 30,2020 |
|---|---|---|
| 284 $ 1,938 48 For the nine-month period ended September 30,2020 |
||
| 854 $ 5,957 106 |
-
F. For the nine-month periods ended September 30, 2021 and 2020, the Group’s total cash outflow for leases were $14,747 and $12,659, respectively.
-
G. Extension and termination options
In determining the lease term, the Group takes into consideration all facts and circumstances that create an economic incentive to exercise an extension option. The assessment of lease period is reviewed if a significant event occurs which affects the assessment.
(9) Investment property
| Investment property | ||||||
|---|---|---|---|---|---|---|
| 2021 | ||||||
| Land | Buildings and structures | Total | ||||
| At January 1 | ||||||
| Cost | $ | 587,286 |
$ | 1,054,765 |
$ | 1,642,051 |
| Accumulated depreciation | ( | 3,879) | ( | 231,586) | ( | 235,465) |
| $ | 583,407 |
$ | 823,179 |
$ | 1,406,586 |
|
| At January 1 | $ | 583,407 |
$ | 823,179 |
$ | 1,406,586 |
| Depreciation charge | ( | 222) |
( | 18,627) |
( | 18,849) |
| Net exchange differences | ( | 158) | ( | 10,243) | ( | 10,401) |
| At September 30 | $ | 583,027 |
$ | 794,309 |
$ | 1,377,336 |
| At September 30 | ||||||
| Cost | $ | 587,064 |
$ | 1,041,687 |
$ | 1,628,751 |
| Accumulated depreciation | ( | 4,037) | ( | 247,378) | ( | 251,415) |
| $ | 583,027 |
$ | 794,309 |
$ | 1,377,336 |
~25~
| At January 1 Cost Accumulated depreciation At January 1 Depreciation charge At September 30 At September 30 Cost Accumulated depreciation |
2020 | Total 819,242 $ 55,509) 763,733 $ 763,733 $ 5,113) 758,620 $ 819,242 $ 60,622) 758,620 $ |
|
|---|---|---|---|
| Land 573,532 $ - ( 573,532 $ 573,532 $ - ( 573,532 $ 573,532 $ - ( 573,532 $ |
Buildingsand structures 245,710 $ 55,509) ( 190,201 $ 190,201 $ 5,113) ( 185,088 $ 245,710 $ 60,622) ( 185,088 $ |
- A. Rental income from investment property and direct operating expenses arising from investment property are shown below:
| property are shown below: | ||
|---|---|---|
| Rental income from investment property Direct operating expenses arising from the investment property that generated rental income during the period Rental income from investment property Direct operating expenses arising from the investment property that generated rental income during the year |
For the three-month period ended September 30,2021 24,792 $ 11,111 $ For the nine-month period ended September 30,2021 70,861 $ 31,953 $ |
For the three-month period ended September 30,2020 |
| 6,886 $ |
||
| 2,070 $ |
||
| For the nine-month period ended September 30,2020 |
||
| 20,191 $ |
||
| 6,203 $ |
-
B. The fair value of the investment property held by the Group as at September 30, 2021, December 31, 2020, and September 30, 2020 all amounted to $1,641,198, $1,632,152 and $870,022, respectively, which were valued by independent appraisers. Valuations were made using the comparative method and income approach to perform evaluation capitalization.
-
C. There was no capitalization of borrowing interests attributable to investment property.
-
D. Information about the investment property that was pledged to others as collaterals is provided in Note 8.
~26~
(10) Intangible assets
| Intangible assets | ||||||
|---|---|---|---|---|---|---|
| 2021 | 2020 | |||||
| At January 1 | ||||||
| Cost | $ | 380,197 |
$ | 245,090 |
||
| Accumulated amortisation | ( | 164,936) | ( | 91,549) | ||
| $ | 215,261 |
$ | 153,541 |
|||
| At January 1 | $ | 215,261 |
$ | 153,541 |
||
| Additions | 125,612 | 55,333 | ||||
| Adjustments | - | 97,837 | ||||
| Amortisation charge | ( | 68,896) |
( | 65,486) |
||
| Net exchange differences | ( | 1,384) | ( | 1,930) | ||
| At September 30 | $ | 270,593 |
$ | 239,295 |
||
| At September 30 | ||||||
| Cost | $ | 451,054 |
$ | 380,111 |
||
| Accumulated amortisation | ( | 180,461) | ( | 140,816) | ||
| $ | 270,593 |
$ | 239,295 |
|||
| A. Details of amortisation on intangible assets are as follows: | ||||||
| For | the three-month | For | the three-month | |||
| period ended | period ended | |||||
| September 30,2021 | September 30,2020 | |||||
| Operating costs | $ | 19 |
$ | 40 |
||
| Operating expense | 22,751 | 27,548 | ||||
| $ | 22,770 |
$ | 27,588 |
|||
| For the nine-month | For the nine-month | |||||
| period ended | period ended | |||||
| September 30,2021 | September 30,2020 | |||||
| Operating costs | $ | 87 |
$ | 119 |
||
| Operating expense | 68,809 | 65,367 | ||||
| $ | 68,896 |
$ | 65,486 |
B. The Group has no intangible assets pledged to others.
~27~
(11) Short-term borrowings
| Short-term borrowings | ||
|---|---|---|
| Short-term notes and bills payable Type ofborrowings September30,2021 Interestraterange Bank borrowings Unsecured borrowings 2,510,000 $ 0.82%~1.1% Type ofborrowings December31,2020 Interestraterange Bank borrowings Unsecured borrowings 2,330,000 $ 0.82%~0.94% Type ofborrowings September30,2020 Interestraterange Bank borrowings Unsecured borrowings 2,730,000 $ 0.82% ~0.89% September 30,2021 December 31,2020 Commercial paper payable 400,000 $ 300,000 $ Less: Discount on short-term notes and bills payable 61) ( 202) ( 399,939 $ 299,798 $ Interest rate ranges 0.84%~0.88% 0.85%~0.87% |
Collateral None Collateral None Collateral None September 30,2020 - $ - - $ - |
|
(12) Short-term notes and bills payable
- (13) Long term borrowings
Borrowing period Interest rate Type of borrowings and repayment term range Collateral December 31, 2020 Secured borrowings Borrowing period is from August 24, 2018 to May 8, 2021. Revolving Yes credit facility. 0.8%~1% (Note) $ 250,000 Less: Current portion (classified under other current liabilities) ( 250,000) - $
As at September 30, 2021 and 2020: None.
During the terms of the unsecured borrowing, in accordance with the unsecured borrowing agreements contracted with bank, the Group is required to maintain a consolidated net value over $8 billion and a debt ratio under 100% based on the annual consolidated financial statements and the semi-annual consolidated financial statements.
Note: Information about collateral for long-term borrowings is provided in Note 8. The mortgage has been cancelled on June 28, 2021.
~28~
(14) Pensions
-
A. (a) The Company and its domestic subsidiaries have a defined benefit pension plan in accordance with the Labor Standards Act, covering all regular employees’ service years prior to the enforcement of the Labor Pension Act on July 1, 2005 and service years thereafter of employees who chose to continue to be subject to the pension mechanism under the Act. Under the defined benefit pension plan, two units are accrued for each year of service for the first 15 years and one unit for each additional year thereafter, subject to a maximum of 45 units. Pension benefits are based on the number of units accrued and the average monthly salaries and wages of the last 6 months prior to retirement. The Group contributes monthly an amount equal to 2% of the employees’ monthly salaries and wages to the retirement fund deposited with Bank of Taiwan, the trustee, under the name of the independent retirement fund committee.
-
(b) For the aforementioned pension plan, the Group recognised pension costs of $0, $0, $43 and $76 for the three-month and nine-month periods ended September 30, 2021 and 2020, respectively.
-
(c) Expected contributions to the defined benefit pension plans of the Group for the year ending December 31, 2022 amount to $12.
-
B.(a) Effective July 1, 2005, the Company and its domestic subsidiaries have established a defined contribution pension plan (the “New Plan”) under the Labor Pension Act (the “Act”), covering all regular employees with R.O.C. nationality. Under the New Plan, the Company and its domestic subsidiaries contribute monthly an amount based on 6% of the employees’ monthly salaries and wages to the employees’ individual pension accounts at the Bureau of Labor Insurance. The benefits accrued are paid monthly or in lump sum upon termination of employment. The pension costs under defined contribution pension plans of the Group for the three-month and nine-month periods ended September 30, 2021 and 2020, were $9,122, $7,556, $25,463 and $22,175, respectively, under the above pension scheme.
-
(b) The foreign subsidiaries provided defined contribution plans for its employees. Pursuant to local regulations, such employees and the subsidiaries each make contributions based on a certain percentage based of the salaries and wages to the pension funds. The subsidiaries had recognised pension costs of $4,526, $240, $12,485 and $1,762 for the three-month and ninemonth periods ended September 30, 2021 and 2020, respectively.
~29~
(15) Share-based payments
- A. For the nine-month periods ended September 30, 2021 and 2020, the Group’s share-based payment arrangements were as follows:
| Type of arrangement | Grant date | Quantity granted (share in thousands) |
Contract period |
Vesting conditions |
|---|---|---|---|---|
| Employee stock options " Plan for restricted shares to employee(2018-1) " Plan for restricted shares to employee(2019-1) " " Treasury stock transferred to employees " |
October 28, 2011 March 21, 2012 August 12, 2019 January 20, 2020 August 12, 2019 January 20, 2020 April 24, 2020 March 9, 2021 May 17, 2021 |
3,000 3,000 630 2,196 820 2,030 86 2,000 2,000 |
9.2 years 8.9 years 3 years 3 years 3 years 3 years 3 years - - |
Note 1 Note 1 Note 2, Note 3 Note 2, Note 3 Note 2, Note 3 Note 2, Note 3 Note 2, Note 3 Immediately vested Immediately vested |
Note 1: 2 years’ service vest 40%, 3 years’ service vest 70%, 4 years’ service vest 100%.
-
Note 2: The restricted shares were issued at no consideration to the Company’s existing employees whose service years have reached 1 year, 2 years and 3 years and who achieved the performance requirement. The vested ratio is 40%, 30% and 30%, respectively. If employees who are entitled to receive restricted stocks do not meet the vesting conditions, the Company will redeem at no consideration and retire those shares.
-
Note 3:The stocks and dividends distributed to employees during the vesting period shall be given by the Company at no consideration. Employees are not required to return the stocks and dividends if they resign during the vesting period.
~30~
-
B. Details of the share-based payment arrangements are as follows:
-
(a) For the nine-month periods ended September 30, 2021 and 2020, the information on the share options and the weighted number of average exercise price of compensation plan employee stock options are as follows:
| Options outstanding at beginning of the period Option expired Options outstanding at end of the period Options exercisable at end of the period |
Weighted-average exercise price No. of options (in NT dollars)(Note) - - $ - - - - - - September 30,2021 For the nine-month period ended |
Weighted-average exercise price No. of options (in NT dollars)(Note) 1,701 29.81 $ 60) ( 28.80 1,641 28.75 1,641 28.75 September 30,2020 For the nine-month period ended |
Weighted-average exercise price No. of options (in NT dollars)(Note) 1,701 29.81 $ 60) ( 28.80 1,641 28.75 1,641 28.75 September 30,2020 For the nine-month period ended |
|---|---|---|---|
| No. of options - - - - |
No. of options 1,701 60) ( 1,641 1,641 |
||
| 29.81 $ 28.80 28.75 28.75 |
-
Note: The exercise price of stock options was adjusted based on the cash dividends, stock dividends and cash capital reduction per share distributed.
-
(b) No stock options were exercised during the three-month and nine-month periods ended September 30, 2021 and 2020.
-
(c) The expiry date and exercise price of stock options outstanding at balance sheet date are as follows:
September 30, 2021: None.
| follows: September 30, |
2021: None. | ||||
|---|---|---|---|---|---|
| Issue dateapproved | Expiry date | December | Exercise price (in NT dollars) (Note) 28.8 $ 28.7 31,2020 |
September30,2020 | |
| No. of shares (in thousands) - - |
No. of shares (in thousands) 860 781 |
Exercise price (in NT dollars) (Note) |
|||
| October 28, 2011 March 21, 2012 |
December 31, 2020 December 31, 2020 |
28.8 $ 28.7 |
Note: The exercise price of stock options was adjusted based on the cash dividends, stock dividends and cash capital reduction per share distributed.
~31~
- (d) The fair value of stock options granted is measured using the Black-Scholes option-pricing model. Relevant information is as follows:
| Type of arrangement |
Grant date | Stock price (in NT dollars) |
Exercise price (Note) (in NT dollars) |
Expected price volatility |
Expected option life |
Expected dividends |
Risk- free interest rate |
Fair value per unit (in NT dollars) |
|---|---|---|---|---|---|---|---|---|
| Employee stock options " |
- - |
30.27% 33.54% |
5 years 4.9 years |
1.4% 1.4% |
1.18% 1.08% |
7.42 $ 7.35 |
Note: The exercise price of stock options was adjusted based on the cash dividends, stock dividends and cash capital reduction per share distributed.
-
C. Restricted shares to employees:
-
(a) The information on restricted shares to employees is as follows (share in thousands):
| For the nine-month | For the nine-month | |||
|---|---|---|---|---|
| period ended | period ended | |||
| September 30,2021 | September 30,2020 | |||
| Shares ungranted beginning balance | 4,968 | 1,350 | ||
| Given at period (Notes 1 and 2) | - | 4,312 | ||
| Shares exercised | ( | 1,993) |
( | 518) |
| Shares forfeited - retired | ( | 183) |
( | 130) |
| Shares forfeited - not retired | ( | 48) | - | |
| Shares ungranted ending balance | 2,744 | 5,014 |
- Note 1: For the restricted stocks granted with the compensation cost accounted for using the fair vale method, the fair values on the grant date are calculated based on the closing price on the grant date.
- Note 2: The fair value of restricted stocks granted in January 20 and April 24, 2020 was $22.8 (in NT dollars) and $18.2 (in NT dollars).
-
(b) For the nine-month period ended September 30, 2021, the Company collected 231 thousand shares of restricted shares because certain employees did not meet the vesting condition, and the change of registration has been completed for 183 thousand shares.
-
D. For the nine-month period ended September 30, 2021, the weighted-average exercise price of treasury stock transferred to employees was $20.38 (in NT dollars).
~32~
E. Expenses incurred on share-based payment transactions are shown below:
| Provisions Equity-settled Equity-settled At January 1, 2021 Additional provisions Reversed during the period Exchange differences At September 30, 2021 Current Non-current |
September 30,2021 11,497 $ 166,237 $ |
For the three-month period ended For the three-month period ended September 30,2021 September 30,2020 5,886 $ 17,770 $ For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 64,404 $ 53,939 $ Warranty 169,690 $ 20,074 12,014) ( 16) ( 177,734 $ December 31,2020 September 30,2020 9,295 $ 7,955 $ 160,395 $ 156,267 $ |
|---|---|---|
(16) Provisions
The Group gives warranties on digital image technology application products sold. Provision for warranty is estimated based on historical warranty data of digital image technology application products.
(17) Share capital
As of September 30, 2021, the Company’s authorised capital was $5,000,000, consisting of 500,000 thousand shares of ordinary stock, and the paid-in capital was $2,792,659 (including $486 recalled
but doesn’t retire ) with a par value of $10 (in NT dollars) per share.
- A. Movements in the number of the Company’s ordinary shares outstanding are as follows (share in thousands):
| (share in thousands): | ||||
|---|---|---|---|---|
| 2021 | 2020 | |||
| At January 1 | 268,497 | 275,361 | ||
| Treasury stock transferred to employees | 2,000 | - | ||
| Establish employee restricted shares | - | 4,312 | ||
| Retired restricted shares to employees that | ||||
| did not meet the vesting conditions | ( | 183) |
( | 130) |
| Recalled restricted shares to employees that | ||||
| did not meet the vesting conditions | ( | 48) |
- | |
| Shares repurchases | - | ( | 11,000) | |
| At September 30 | 270,266 | 268,543 |
~33~
B. Treasury shares
- (a) Reason for share reacquisition and the number of the Company’s treasury shares are as follows :
| follows : | |||
|---|---|---|---|
| Name of company holdingthe shares |
Reason for reacquisition To be reissued to employees Reason for reacquisition To be reissued to employees Reason for reacquisition To be reissued to employees |
September | 30,2021 |
| Number of shares (share in thousands) Carryingamount 9,000 167,127 $ Number of shares (sharein thousands) Carryingamount 11,000 209,287 $ December31,2020 Number of shares (share in thousands) Carryingamount 11,000 209,287 $ September30,2020 |
Carryingamount | ||
| The Company Name of company holdingthe shares |
167,127 $ |
||
| The Company Name of company holdingthe shares |
|||
| The Company |
-
(b) Pursuant to the R.O.C. Securities and Exchange Act, the number of shares bought back as treasury share should not exceed 10% of the number of the Company’s issued and outstanding shares and the amount bought back should not exceed the sum of retained earnings, paid-in capital in excess of par value and realised capital surplus.
-
(c) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should not be pledged as collateral and is not entitled to dividends before it is reissued.
-
(d) Pursuant to the R.O.C. Securities and Exchange Act, treasury shares should be reissued to the employees within five years from the reacquisition date and shares not reissued within the five-year period are to be retired.
(18) Capital surplus
Pursuant to the R.O.C. Company Act, capital surplus arising from paid-in capital in excess of par value on issuance of common stocks and donations can be used to cover accumulated deficit or to issue new stocks or cash to shareholders in proportion to their share ownership, provided that the Company has no accumulated deficit. Further, the R.O.C. Securities and Exchange Act requires that the amount of capital surplus to be capitalised mentioned above should not exceed 10% of the paidin capital each year. Capital surplus should not be used to cover accumulated deficit unless the legal reserve is insufficient.
~34~
2021
| Share Employee stock Difference between consideration and carrying amount of subsidiaries acquired or premium options disposed At January 1 1,821,473 $ 49,102 $ 1,534 $ Changes in ownership interests in subsidiaries - - - Treasury stock transferred to employees - - - Employee restricted share granted 25,632 - - Retired restricted shares to employees that did not meet the vesting conditions - - - At September 30 1,847,105 $ 49,102 $ 1,534 $ Share Employee stock Difference between consideration and carrying amount of subsidiaries acquired or premium options disposed At January 1 1,814,532 $ 49,102 $ 1,534 $ Issuance of restricted shares to employees - - - Employee restricted share granted 6,941 - - Retirement of employee restricted shares - - - At September 30 1,821,473 $ 49,102 $ 1,534 $ |
Share Employee stock Difference between consideration and carrying amount of subsidiaries acquired or premium options disposed At January 1 1,821,473 $ 49,102 $ 1,534 $ Changes in ownership interests in subsidiaries - - - Treasury stock transferred to employees - - - Employee restricted share granted 25,632 - - Retired restricted shares to employees that did not meet the vesting conditions - - - At September 30 1,847,105 $ 49,102 $ 1,534 $ Share Employee stock Difference between consideration and carrying amount of subsidiaries acquired or premium options disposed At January 1 1,814,532 $ 49,102 $ 1,534 $ Issuance of restricted shares to employees - - - Employee restricted share granted 6,941 - - Retirement of employee restricted shares - - - At September 30 1,821,473 $ 49,102 $ 1,534 $ |
Share Employee stock premium options 1,821,473 $ 49,102 $ - - - - 25,632 - - - 1,847,105 $ 49,102 $ |
Difference between consideration and carrying amount of subsidiaries acquired or disposed 1,534 $ - - - - 1,534 $ |
Changes in ownership interests in subsidiaries 397,909 $ 11,831) ( - - - 386,078 $ 2020 |
Proceeds from sales of treasury shares 1,455 $ - 42,464 - - 43,919 $ |
|---|---|---|---|---|---|
| Changes in ownership interests in subsidiaries 395,774 $ - - - 395,774 $ |
Proceeds from sales of treasury Restricted shares to shares employees 1,455 $ 18,090 $ - 54,798 - 6,941) ( - 1,605) ( ( 1,455 $ 64,342 $ |
(19) Retained earnings
- A. According to the Company’s Articles of Incorporation, the annual earnings, if any, shall first be used to pay all taxes and offset prior years’ operating losses and then 10% of the remaining amount shall be set aside as legal reserve. Special reserve shall be set aside in accordance with the rules. The remaining amount plus the unappropriated earnings of prior years were distributed in new shares, which were proposed by the Board of Directors and resolved at the shareholders’ meeting.
All or some of the dividends and bonus could, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, be distributed in the form of cash and reported at the shareholders’ meeting.
~35~
-
B. The amount of dividends appropriated is based on the Company’s current year’s net income and prior years’ retained earnings, taking into account the Company’s financial structure and future operating plans. The distribution ratio of cash dividends to stock dividends is based on the Company’s funding status, diluted earnings per share and other factors. According to the dividend policy adopted by the Board of Directors, cash dividends shall account for at least 20% of the total dividends distributed.
-
C. Except for covering accumulated deficit or issuing new stocks or cash to shareholders in proportion to their share ownership, the legal reserve shall not be used for any other purpose. The use of legal reserve for the issuance of stocks or cash to shareholders in proportion to their share ownership is permitted, provided that the balance of the reserve exceeds 25% of the Company’s paid-in capital.
-
D. (a) In accordance with the regulations, the Company shall set aside special reserve from the debit balance on other equity items at the balance sheet date before distributing earnings. When debit balance on other equity items is reversed subsequently, the reversed amount could be included in the distributable earnings.
-
(b) The amounts previously set aside by the Company as special reserve on initial application of IFRSs in accordance with Order No. Financial-Supervisory-Securities-Corporate1010012865, dated April 6, 2012, shall be reversed proportionately when the relevant assets are used, disposed of or reclassified subsequently. Such amounts are reversed upon disposal or reclassified if the assets are investment property of land, and reversed over the use period if the assets are investment property other than land.
-
E. The appropriation of 2020 and 2019 earnings had been resolved at the stockholders’ meeting on August 26, 2021 and June 12, 2020, respectively. Details are summarized below:
| Legal reserve Special reserve Cash dividends |
Dividends per share Amount (inNTdollars) 15,943 $ 59,231 134,249 0.5 $ 209,423 $ 2020 |
2019 | 2019 |
|---|---|---|---|
| Amount 15,943 $ 59,231 134,249 209,423 $ |
Amount 8,316 $ 156,646 139,794 304,756 $ |
Dividends per share (inNTdollars) |
|
| 0.5 $ |
The appropriation of 2020 and 2019 earnings were the same as that approved by the Board of Directors on March 25, 2021 and March 20, 2020, respectively.
~36~
(20) Other equity items
| Other equity items | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | |||||||||||||||||
| Unrealized | |||||||||||||||||
| Foreign currency | losses on | Unearned | |||||||||||||||
| translation | valuation | compensation | Total | ||||||||||||||
| At January 1 | ($ | 550,536) |
($ | 101,020) |
($ | 46,142) |
($ | 697,698) |
|||||||||
| Valuation adjustment | - | 758 | - | 758 | |||||||||||||
| Valuation adjustment to retained | - | 1,572 | - | 1,572 | |||||||||||||
| earnings | |||||||||||||||||
| Currency translation differences: | |||||||||||||||||
| -Group | ( | 136,285) |
- | - | ( | 136,285) |
|||||||||||
| Retirement of restricted shares | |||||||||||||||||
| to employees | - | - | 5,235 | 5,235 | |||||||||||||
| Share-based payment transactions | - | - | 21,814 | 21,814 | |||||||||||||
| At September 30 | ($ | 686,821) |
($ | 98,690) |
($ | 19,093) |
($ | 804,604) |
|||||||||
| 2020 | |||||||||||||||||
| Unrealized | |||||||||||||||||
| Foreign currency | losses on | Unearned | |||||||||||||||
| translation | valuation | compensation | Total | ||||||||||||||
| At January 1 | ($ | 494,335) |
($ | 97,990) |
($ | 23,034) |
($ | 615,359) |
|||||||||
| Valuation adjustment | - | ( | 352) |
- | ( | 352) |
|||||||||||
| Currency translation differences: | |||||||||||||||||
| -Group | ( | 94,976) |
- | - | ( | 94,976) |
|||||||||||
| Issuance of restricted shares to | |||||||||||||||||
| employees | - | - | ( | 97,918) |
( | 97,918) |
|||||||||||
| Retirement of restricted shares | - | - | 2,905 | 2,905 | |||||||||||||
| to employees | |||||||||||||||||
| Share-based payment transactions | - | - | 53,939 | 53,939 | |||||||||||||
| At September 30 | ($ | 589,311) |
($ | 98,342) |
($ | 64,108) |
($ | 751,761) |
(21) Operating revenue
| Operating revenue | ||
|---|---|---|
| Revenue from contracts with customers Revenue from contracts with customers |
For the three-month period ended September 30,2021 2,470,362 $ For the nine-month period ended September 30,2021 6,753,566 $ |
For the three-month period ended September 30,2020 |
| 1,615,475 $ |
||
| For the nine-month period ended September 30,2020 |
||
| 4,252,973 $ |
~37~
A. Disaggregation of revenue from contracts with customers
The Group derives revenue from the transfer of goods and services over time and at a point in time in the following major geographical regions:
| For the three-month period ended September 30,2021 Revenue from external customer contracts Timing of revenue recognition At a point in time Over time Total For the three-month period ended September 30,2020 Revenue from external customer contracts Timing of revenue recognition At a point in time Over time Total For the nine-month period ended September 30,2021 Revenue from external customer contracts Timing of revenue recognition At a point in time Over time Total |
Asia 1,448,256 $ 1,438,047 $ 10,209 1,448,256 $ Asia 960,872 $ 934,534 $ 26,338 960,872 $ Asia 3,992,293 $ 3,961,618 $ 30,675 3,992,293 $ |
Europe 384,622 $ 384,622 $ - 384,622 $ Europe 280,387 $ 280,387 $ - 280,387 $ Europe 925,413 $ 925,413 $ - 925,413 $ |
America 636,425 $ 636,425 $ - 636,425 $ America 374,117 $ 374,117 $ - 374,117 $ America 1,830,084 $ 1,830,084 $ - 1,830,084 $ |
Taiwan 1,059 $ 1,059 $ - 1,059 $ Taiwan 99 $ 99 $ - 99 $ Taiwan 5,776 $ 5,776 $ - 5,776 $ |
Total |
|---|---|---|---|---|---|
| 2,470,362 $ |
|||||
| 2,460,153 $ 10,209 |
|||||
| 2,470,362 $ |
|||||
| Total | |||||
| 1,615,475 $ |
|||||
| 1,589,137 $ 26,338 |
|||||
| 1,615,475 $ |
|||||
| Total | |||||
| 6,753,566 $ |
|||||
| 6,722,891 $ 30,675 |
|||||
| 6,753,566 $ |
~38~
| For the nine-month period ended September 30,2020 Revenue from external customer contracts Timing of revenue recognition At a point in time Over time Total |
Asia 2,323,257 $ 2,252,088 $ 71,169 2,323,257 $ |
Europe 784,872 $ 784,872 $ - 784,872 $ |
America 1,027,581 $ 1,027,581 $ - 1,027,581 $ |
Taiwan 117,263 $ 117,263 $ - 117,263 $ |
Total |
|---|---|---|---|---|---|
| 4,252,973 $ |
|||||
| 4,181,804 $ 71,169 |
|||||
| 4,252,973 $ |
- B. Contract liabilities
The Group has recognised the following revenue-related contract liabilities:
| Contract liabilities | September 30,2021 | December 31,2020 | September 30,2020 | January1,2020 |
|---|---|---|---|---|
| 147,144 $ |
32,568 $ |
92,865 $ |
34,096 $ |
- C. Revenue recognised that was included in the contract liability balance at the beginning of the period
| Revenue recognised that was included in the contract liability balance at the beginning of the period Revenue recognised that was included in the contract liability balance at the beginning of the period |
For the three-month period ended September 30,2021 -$For the nine-month period ended September 30,2021 25,009$ |
For the three-month period ended September 30,2020 |
|---|---|---|
16,125$ |
||
| For the nine-month period ended September 30,2020 |
||
25,917$ |
~39~
(22) Interest income
| Interest income | ||
|---|---|---|
| Other income Interest income from bank deposits Interest income from financial assets measured at amortised cost Other interest income Interest income from bank deposits Interest income from financial assets measured at amortised cost Other interest income Rent income Dividend income Other income - others Rent income Dividend income Other income - others |
For the three-month period ended September 30,2021 6,531 $ 11,042 9 17,582 $ For the nine-month period ended September 30,2021 19,285 $ 34,635 38 53,958 $ For the three-month period ended September 30,2021 13,435 $ 1,526 5,934 20,895 $ For the nine-month period ended September 30,2021 35,785 $ 1,526 13,955 51,266 $ |
For the three-month period ended September 30,2020 |
| 9,434 $ 13,296 8 |
||
| 22,738 $ |
||
| For the nine-month period ended September 30,2020 |
||
| 48,909 $ 32,874 23 |
||
| 81,806 $ |
||
| For the three-month period ended September 30,2020 |
||
| 4,710 $ 1,526 2,218 |
||
| 8,454 $ |
||
| For the nine-month period ended September 30,2020 |
||
| 25,891 $ 1,526 8,073 |
||
| 35,490 $ |
(23) Other income
~40~
(24) Other gains and losses
| Finance costs For the three-month period ended September 30,2021 Gain on disposal of property, plant and equipment 291 $ Net currency exchange gains 2,679 Net gains on financial assets at fair value through profit 307 Other expenses - ( Total 3,277 $ For the nine-month period ended September 30,2021 Loss on disposal of property, plant and equipment 29) ($ Net currency exchange gains 3,577 Net gains on financial assets at fair value through profit 27,931 Other expenses 78) ( ( Total 31,401 $ For the three-month period ended September 30,2021 Interest expense : Bank loan 5,348 $ Lease liabilities 277 Other 900 6,525 $ For the nine-month period ended September 30,2021 Interest expense : Bank loan 16,291 $ Lease liabilities 831 Other 1,867 18,989 $ |
For the three-month period ended September 30,2020 - $ 1,537 6,409 124) 7,822 $ For the nine-month period ended September 30,2020 - $ 5,879 7,920 1,655) 12,144 $ For the three-month period ended September 30,2020 5,831 $ 284 112 6,227 $ For the nine-month period ended September 30,2020 17,538 $ 854 521 18,913 $ |
|---|---|
(25) Finance costs
~41~
(26) Expenses by nature
| Expenses by nature | ||
|---|---|---|
| Employee benefit expenses Employee benefit expenses Depreciation charges on property, plant and equipment Depreciation charges on right-of-use assets Depreciation charges on investment property Amortisation charges on intangible assets Employee benefit expenses Depreciation charges on property, plant and equipment Depreciation charges on right-of-use assets Depreciation charges on investment property Amortisation charges on intangible assets Wages and salaries Labour and health insurance fees Pension costs Other personnel expenses Total Wages and salaries Labour and health insurance fees Pension costs Other personnel expenses Total |
For the three-month period ended September 30,2021 392,642 $ 37,581 3,443 6,262 22,770 For the nine-month period ended September 30,2021 1,111,915 $ 112,349 10,591 18,849 68,896 For the three-month period ended September 30,2021 353,222 $ 15,469 13,648 10,303 392,642 $ For the nine-month period ended September 30,2021 999,211 $ 45,991 37,991 28,722 1,111,915 $ |
For the three-month period ended September 30,2020 |
| 306,278 $ 41,316 2,495 1,704 27,588 For the nine-month period ended September 30,2020 |
||
| 862,627 $ 124,219 6,763 5,113 65,486 For the three-month period ended September 30,2020 |
||
| 276,754 $ 13,149 7,796 8,579 |
||
| 306,278 $ |
||
| For the nine-month period ended September 30,2020 |
||
| 777,604 $ 38,120 24,013 22,890 |
||
| 862,627 $ |
(27) Employee benefit expenses
A. According to the Articles of Incorporation of the Company, when distributing earnings, the Company shall distribute compensation to the employees and pay remuneration to the directors that account for 10% to 20% and no higher than 2%, respectively, of distributable profit of the current period. If a company has accumulated deficit, earnings should be channeled to cover losses. Employees’ compensation can be distributed in the form of shares or in cash. Employees
~42~
of subsidiaries that the Company holds more than 50% shareholding are entitled to receive aforementioned stock or cash.
- Abovementioned distributable profit of the current period refers to the pre-tax profit before deduction of employees’ compensation and directors’ remuneration. A company may, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, have the profit distributed as employees’ compensation and directors’ remuneration; and in addition thereto a report of such distribution shall be submitted to the shareholders’ meeting.
-
B. For the three-month and nine-month periods ended September 30, 2021 and 2020, employees’ compensation was accrued at $19,438, $8,961, $37,059 and $26,545, respectively; directors’ remuneration was accrued at $2,592, $1,195, $4,941 and $3,539, respectively. The aforementioned amounts were recognised in salary expenses.
-
Employees’ compensation and directors’ and supervisors’ remuneration for 2020 amounting to $31,624 and $4,217, respectively, as resolved at the meeting of Board of Directors were in agreement with those amounts recognised in the 2020 financial statements.
-
Information about employees’ compensation and directors’ remuneration of the Company as resolved at the meeting of Board of Directors will be posted in the “Market Observation Post System” at the website of the Taiwan Stock Exchange.
-
-
(28) Income tax
-
A. Income tax expense
- (a) Components of income tax expense:
| e tax ome tax expense Components of income tax expense: |
||
|---|---|---|
| Current tax: Current tax on profits for the period Tax paid outside of the territory of the Republic of China Prior year income tax over estimation Total current tax Deferred tax: Origination and reversal of temporary differences Income tax expense |
For the three-month period ended September 30,2021 26,609 $ 6,119 12 32,740 9,439 42,179 $ |
For the three-month period ended September 30,2020 |
| 21,765 $ 954 - |
||
| 22,719 | ||
| 5,817 | ||
| 28,536 $ |
~43~
| For the nine-month | For the nine-month | |||||
|---|---|---|---|---|---|---|
| period ended | period ended | |||||
| September 30,2021 | September 30,2020 | |||||
| Current tax: | ||||||
| Current tax on profits for the period | $ | 80,100 |
$ | 44,990 |
||
| Charge on unappropriated retained earnings | 3,418 | 7,315 | ||||
| Tax paid outside of the territory of | ||||||
| the Republic of China | 12,768 | 3,696 | ||||
| Prior year income tax over estimation | ( | 5,570) | ( | 273) | ||
| Total current tax | 90,716 | 55,728 | ||||
| Deferred tax: | ||||||
| Origination and reversal of | ||||||
| temporary differences | ( | 647) | 19,765 | |||
| Income tax expense | $ | 90,069 |
$ | 75,493 |
||
| (b) The income tax charged to other comprehensive | income is as follows: | |||||
| For the three-month | For the three-month | |||||
| period ended | period ended | |||||
| September 30,2021 | September 30,2020 | |||||
| Changes in fair value of financial assets at | ||||||
| fair value through other comprehensive | ||||||
| income | $ | - |
($ | 28) |
||
| Translation differences of foreign operations | ( | 5,145) | 11,249 | |||
| ($ | 5,145) |
$ | 11,221 |
|||
| For the nine-month | For the nine-month | |||||
| period ended | period ended | |||||
| September 30,2021 | September 30,2020 | |||||
| Changes in fair value of financial assets at | ||||||
| fair value through other comprehensive | ||||||
| income | $ | 255 |
($ | 88) |
||
| Translation differences of foreign operations | ( | 34,071) | ( | 23,744) | ||
| ($ | 33,816) |
($ | 23,832) |
- B. The Company’s income tax returns through 2018 have been assessed and approved by the Tax Authority.
~44~
(29) Earnings per share
| Earnings per share | |||
|---|---|---|---|
| Basic earnings per share Profit attributable to ordinary shareholders of the parent Diluted earnings per share Profit attributable to ordinary shareholders of the parent Assumed conversion of all dilutive potential ordinary shares Restricted shares to employees Treasure stock transferred to employees Employees’ bonus Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares Basic earnings per share Profit attributable to ordinary shareholders of the parent Diluted earnings per share Profit attributable to ordinary shareholders of the parent Assumed conversion of all dilutive potential ordinary shares Restricted shares to employees Employees’ bonus Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares |
For the three-monthperiod endedSeptember 30,2021 | ||
| Weighted average number of ordinary shares outstanding Earnings per share Amount after tax (share in thousands) (in dollars) 94,084 $ 265,573 0.35 $ 94,084 $ - 2,665 - 912 - 1,065 94,084 $ 270,215 0.35 $ For the three-monthperiod endedSeptember 30,2020 |
Earnings per share (in dollars) |
||
| 0.35 $ |
|||
| 0.35 $ |
|||
| Amount after tax 41,454 $ 41,454 $ - - 41,454 $ |
Weighted average number of ordinary shares outstanding (share in thousands) 263,186 2,963 1,068 267,217 |
Earnings per share (in dollars) |
|
| 0.16 $ |
|||
| 0.16 $ |
~45~
| Transactions with non-controlling interest 1. In January, 2021, the Group disposed 25% of its shares in subsidiary—Altek Optical Technology (Kunshan) Co., Ltd. and in February 11.67% of its shares in subsidiary—Altek Medical Holding (Cayman) Co., Ltd. Therefore, the Group reduced its shareholding in subsidiaries in the above transactions. Weighted average number of ordinary shares outstanding Earnings per share Amount after tax (share in thousands) (in dollars) Basic earnings per share Profit attributable to ordinary shareholders of the parent 186,808 $ 264,952 0.71 $ Diluted earnings per share Profit attributable to ordinary shareholders of the parent 186,808 $ Assumed conversion of all dilutive potential ordinary shares Restricted shares to employees - 3,029 Treasure stock transferred to employees - 896 Employees’ bonus - 1,334 Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares 186,808 $ 270,211 0.69 $ For the nine-monthperiod endedSeptember 30,2021 Weighted average number of ordinary shares outstanding Earnings per share Amount after tax (share in thousands) (in dollars) Basic earnings per share Profit attributable to ordinary shareholders of the parent 123,272 $ 266,507 0.46 $ Diluted earnings per share Profit attributable to ordinary shareholders of the parent 123,272 $ Assumed conversion of all dilutive potential ordinary shares Restricted shares to employees - 2,664 Employees’ bonus - 1,362 Profit attributable to ordinary shareholders of the parent plus assumed conversion of all dilutive potential ordinary shares 123,272 $ 270,533 0.46 $ For the nine-monthperiod ended September 30,2020 |
For the nine-monthperiod endedSeptember 30,2021 | For the nine-monthperiod endedSeptember 30,2021 | |
|---|---|---|---|
| Earnings per share (in dollars) |
|||
| 0.71 $ |
|||
| 0.69 $ |
|||
(30) Transactions with non-controlling interest
~46~
- Altek Medical Holding (Cayman) Co., Ltd., a subsidiary company of the group, increased its capital in January 2021. The Group did not subscribe to the capital increase which resulted in a reduction of 6.15% of its shareholding in accordance with its shareholding ratio. The subsidiary company, Altek Optical Technology (Kunshan) Co., Ltd, increased its capital in February 2021. The Group and the non-controlling interests are subscribed in accordance with the shareholding ratio.
The effect of changes in interests on the equity attributable to owners of the parent is shown below:
| Consideration received from non-controlling interest Non-controlling interests invested in cash Increase in the carrying amount of non-controlling interest Capital surplus |
For the nine-month period ended September30,2021 99,094 $ 70,464 181,389) ( 11,831) ($ |
For the nine-month period ended September30,2020 |
|---|---|---|
| - $ - - |
||
| - $ |
(31) Supplemental cash flow information
A. Investing activities with partial cash payments :
| Acquisition of property, plant, and equipment Add: Property and equipment and construction billings payable at beginning of period Less: Property and equipment and construction billings payable at end of period Cash paid Acquisition of intangible assets Add: Payables at beginning of period Less: Payables at end of period Cash paid |
For the nine-month period ended September30,2021 352,205 $ 4,203 1,074) ( 355,334 $ For the nine-month period ended September 30,2021 125,612 $ 278 378) ( 125,512 $ |
For the nine-month period ended September30,2020 11,558 $ 898 660) ( 11,796 $ For the nine-month period ended September 30,2020 55,333 $ - 450) ( 54,883 $ |
|---|---|---|
~47~
B. Financing activities with no cash flow effects :
| (32) | Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
Changes in liabilities from financing activities For the nine-month period ended For the nine-month period ended September 30,2021 September 30,2020 Declaration of cash dividend 134,249 $ 139,794 $ Short-term borrowings Short-term notes and bills payable Long-term borrowings (Note) Guarantee deposits received Lease liabilities Total January 1, 2021 2,330,000 $ 299,798 $ 250,000 $ 26,480 $ 104,512 $ 3,010,790 $ Changes in cash flow from financing activities 180,000 98,274 250,000) ( 3,279) ( 10,636) ( 14,359 Impact of changes in foreign exchange rate - - - 298) ( 13) ( 311) ( Changes in other non-cash items - 1,867 - - 14,271 16,138 September 30, 2021 2,510,000 $ 399,939 $ - $ 22,903 $ 108,134 $ 3,040,976 $ Short-term borrowings Short-term notes and billspayable Long-term borrowings Guarantee deposits received Lease liabilities Total January 1, 2020 2,200,000 $ 229,962 $ - $ 20,326 $ 102,805 $ 2,553,093 $ Changes in cash flow from financing activities 530,000 230,483) ( - 10,262 6,596) ( 303,183 Impact of changes in foreign exchange rate - - - - 21) ( 21) ( Changes in other non-cash items - 521 - 56) ( 11,025 11,490 September 30, 2020 2,730,000 $ - $ - $ 30,532 $ 107,213 $ 2,867,745 $ |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $ | $ | ||||||||||
| Long-term borrowings (Note) |
Lease liabilities |
||||||||||
January 1, 2021 Changes in cash flow from financing activities Impact of changes in foreign exchange rate Changes in other non-cash items September 30, 2021 January 1, 2020 Changes in cash flow from financing activities Impact of changes in foreign exchange rate Changes in other non-cash items September 30, 2020 |
Short-term borrowings |
||||||||||
| 2,330,000 $ 180,000 - - 2,510,000 $ Short-term borrowings |
299,798 $ 98,274 - 1,867 399,939 $ Short-term notes and billspayable |
250,000 $ 250,000) ( - - - $ Long-term borrowings |
26,480 $ 3,279) ( 298) ( - 22,903 $ Guarantee deposits received |
104,512 $ 10,636) ( 13) ( 14,271 108,134 $ Lease liabilities |
3,010,790 $ 14,359 311) ( 16,138 3,040,976 $ Total |
||||||
| 2,200,000 $ 530,000 - - 2,730,000 $ |
229,962 $ 230,483) ( - 521 - $ |
- $ - - - - $ |
20,326 $ 10,262 - 56) ( 30,532 $ |
102,805 $ 6,596) ( 21) ( 11,025 107,213 $ |
2,553,093 $ 303,183 21) ( 11,490 2,867,745 $ |
Note: The loan will be due within 1 year and is classified under other current liabilities.
7. RELATED PARTY TRANSACTIONS
(1) Names of related parties and relationship: None.
(2) Significant transactions and balances with related parties:
No significant related party transactions.
~48~
(3) Key management compensation
| Key management compensation | ||
|---|---|---|
| Salaries and other short-term employee benefits Post-employment benefits Share-based payments Total Salaries and other short-term employee benefits Post-employment benefits Share-based payments Total |
For the three-month period ended September 30,2021 11,142 $ 304 1,242 12,688 $ For the nine-month period ended September 30,2021 37,346 $ 798 4,782 42,926 $ |
For the three-month period ended September 30,2020 |
| 9,518 $ 266 4,304 |
||
| 14,088 $ |
||
| For the nine-month period ended September 30,2020 |
||
| 33,096 $ 692 11,935 |
||
| 45,723 $ |
8. PLEDGED ASSETS
The Group’s assets pledged as collateral are as follows:
| Pledged asset | Purpose Long-term borrowings Long-term borrowings |
Bookvalue | September30,2020 737,156 $ 758,620 1,495,776 $ |
|---|---|---|---|
| September30,2021 December31,2020 - $ 734,116 $ - 756,915 - $ 1,491,031 $ |
|||
| Land, buildings and structures Investment property |
9. SIGNIFICANT CONTINGENT LIABILITIES AND UNRECOGNISED CONTRACT
COMMITMENTS
None.
10. SIGNIFICANT DISASTER LOSS
None.
11. SIGNIFICANT SUBSEQUENT EVENT
None.
12. OTHERS
(1) Capital management
The Group’s objectives when managing capital are to safeguard the Group’s ability to continue as a going concern in order to provide returns for shareholders and to maintain an optimal capital structure to reduce the cost of capital. In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends, return capital or issue new shares to achieve the optimal capital structure.
~49~
(2) Financial instruments
A. Financial instruments by category
| ancial instruments Financial instruments by category |
|||
|---|---|---|---|
| Financial assets Financial assets measured at fair value through profit or loss Financial assets at fair value through other comprehensive income Financial assets at amortised cost Cash and cash equivalents Current financial assets at amortised cost Current contract assets Accounts receivable Other accounts receivable Guarantee deposit paid Financial liabilities Financial liabilities at amortised cost Short-term borrowings Short-term notes and bills payable Accounts payable Other accounts payable Long-term borrowings (including current portion) Guarantee deposits received Lease liabilities |
September30,2021 68,441 $ 122,693 $ 5,438,633 $ 1,417,536 - 1,731,226 102,906 39,860 8,730,161 $ September30,2021 2,510,000 $ 399,939 1,747,256 607,376 - 22,903 5,287,474 $ 108,134 $ |
December31,2020 397,893 $ 43,130 $ 5,373,406 $ 1,842,389 4,414 1,273,383 68,825 34,746 8,597,163 $ December31,2020 2,330,000 $ 299,798 1,296,475 485,953 250,000 26,480 4,688,706 $ 104,512 $ |
September30,2020 48,076 $ 45,544 $ 5,813,248 $ 1,803,661 4,415 1,042,950 54,746 31,170 8,750,190 $ September30,2020 2,730,000 $ - 1,013,430 548,621 - 30,532 4,322,583 $ 107,213 $ |
-
B. Financial risk management policies
-
(a) The Group’s activities expose it to a variety of financial risks: market risk (including foreign exchange risk, interest rate risk and price risk), credit risk and liquidity risk. To minimize any adverse effects on the financial performance of the Group, derivative financial instruments, such as foreign exchange forward contracts and foreign currency option contracts are used to hedge certain exchange rate risk, and interest rate swaps are used to fix variable future cash flows. Derivatives are used exclusively for hedging purposes and not as trading or speculative instruments.
~50~
-
(b) Risk management is carried out by a Group treasury department under policies approved by the Board of Directors. Group treasury identifies, evaluates and hedges financial risks in close co-operation with the Group’s operating units. The Board provides written principles for overall risk management, as well as written policies covering specific areas and matters, such as foreign exchange risk, interest rate risk, credit risk, use of derivative financial instruments and non-derivative financial instruments, and investment of excess liquidity.
-
C. Significant financial risks and degrees of financial risks
-
(a) Market risk
Foreign exchange risk
-
i. The Group operates internationally and is exposed to exchange rate risk arising from the transactions of the Company and its subsidiaries used in various functional currency, primarily with respect to the USD and RMB. Exchange rate risk arises from future commercial transactions and recognised assets and liabilities.
-
ii. Management has set up a policy to require group companies to manage their foreign exchange risk against their functional currency. The companies are required to hedge their entire foreign exchange risk exposure with the Group treasury. Exchange rate risk is measured through a forecast of highly probable USD and RMB expenditures. Forward foreign exchange contracts are adopted to minimize the volatility of the exchange rate affecting cost of forecast inventory purchases.
-
iii. The Group has certain investments in foreign operations, whose net assets are exposed to foreign currency translation risk. Currency exposure arising from the net assets of the Group’s foreign operations is managed primarily through borrowings denominated in the relevant foreign currencies.
-
iv. The information on assets and liabilities denominated in foreign currencies whose values would be materially affected by the exchange rate fluctuations is as follows:
~51~
September 30, 2021
| Foreign Currency Amount (In thousands) (Foreign currency: functional currency) Financial assets Monetary items USD:NTD 74,279 USD USD:RMB 56,068 USD Financial liabilities Monetary items USD:NTD 59,928 USD USD:RMB 55,315 USD Foreign Currency Amount (In thousands) (Foreign currency: functional currency) Financial assets Monetary items USD:NTD 60,233 USD USD:RMB 42,521 USD Financial liabilities Monetary items USD:NTD 50,084 USD USD:RMB 40,800 USD |
Foreign Currency Amount (In thousands) 74,279 USD 56,068 USD 59,928 USD 55,315 USD |
||
|---|---|---|---|
| Exchange Rate 28.480 6.5249 28.480 6.5249 |
Book Value (NTD) 1,715,436 $ 1,210,998 1,426,392 $ 1,161,984 |
||
~52~
September 30, 2020
| Foreign Currency Amount (In thousands) (Foreign currency: functional currency) Financial assets Monetary items USD:NTD 40,196 USD USD:RMB 32,733 USD Financial liabilities Monetary items USD:NTD 36,119 USD USD:RMB 29,932 USD |
Exchange Rate 29.100 6.8101 29.100 6.8101 |
Book Value (NTD) 1,169,704 $ 952,530 1,051,063 $ 871,021 |
Effect on Effect on Other Extent of Profit or Comprehensive Variation (Loss) Income(Loss) 1% 11,697 $ - $ 1% 9,525 - 1% 10,511) ($ - $ 1% 8,710) ( - SensitivityAnalysis |
|---|---|---|---|
- v. Total exchange gain including realized and unrealized arising from significant foreign exchange variation on the monetary items held by the Group for the three-month and ninemonth periods ended September 30, 2021 and 2020 amounted to $2,679, $1,537, $3,577 and $5,879, respectively.
Price risk
-
i. The Group’s equity securities, which are exposed to price risk, are the held financial assets at fair value through profit or loss and financial assets at fair value through other comprehensive income.
-
ii. The Group’s investments in equity securities comprise shares issued by the domestic companies. The prices of equity securities would change due to the change of the future value of investee companies. If the prices of these equity securities had increased/decreased by 10% with all other variables held constant, post-tax profit for the nine-month periods ended September 30, 2021 and 2020 would have increased/decreased by $6,844 and $4,808, respectively, as a result of gains/losses on equity securities classified as at fair value through profit or loss. Other components of equity would have increased/decreased by $12,269 and $4,554, respectively, as a result of other comprehensive income classified as equity investment at fair value through other comprehensive income.
Cash flow and fair value interest rate risk
Interest risk arises from the changes of market interest rate causing fluctuation in financial instruments’ fair value or cash received and paid in the future.
The Group raised short-term and long-term borrowings at fixed rates during the nine-month periods ended September 30, 2021 and 2020, and thus had no significant cash flow interest rate risk.
~53~
(b) Credit risk
-
i. Credit risk refers to the risk of financial loss to the Group arising from default by the clients or counterparties of financial instruments on the contract obligations. The main factor is that counterparties could not repay in full the accounts receivable based on the agreed terms.
-
ii. The Group manages their credit risk taking into consideration the entire group’s concern. According to the Group’s credit policy, each local entity in the Group is responsible for managing and analysing the credit risk for each of their new clients before standard payment and delivery terms and conditions are offered. Internal risk control assesses the credit quality of the customers, taking into account their financial position, past experience and other factors. Individual risk limits are set based on internal or external ratings in accordance with limits set by the Board of Directors. The utilisation of credit limits is regularly monitored.
-
iii. The Group measured internal operating procedures, past experience of trading customers, and actual transaction status. If the contract payments were past due over 90 days based on the terms, there has been a significant increase in credit risk on that instrument since initial recognition. If the contract payments were past due over 360 days based on the term, the default has occurred.
-
iv. The following indicators are used to determine whether the credit impairment of debt instruments has occurred:
-
(i) It becomes probable that the issuer will enter bankruptcy or other financial reorganization due to their financial difficulties;
-
(ii) The disappearance of an active market for that financial asset because of financial difficulties;
-
(iii) Default or delinquency in interest or principal repayments;
-
(iv) Adverse changes in national or regional economic conditions that are expected to cause a default.
-
v. The Group classifies customers’ accounts receivable and contract asset in accordance with customer types. The Group applies the simplified approach using loss provision matrix to estimate expected credit loss under the provision matrix basis.
-
vi. The Group wrote-off the financial assets, which cannot be reasonably expected to be recovered, after initiating recourse procedures. However, the Group will continue executing the recourse procedures to secure their rights.
~54~
vii. The Group used the forecastability to adjust historical and timely information to access the default possibility of contract assets and accounts receivable. As of September 30, 2021, December 31, 2020, and September 30, 2020, the provision matrix is as follows:
| September30,2021 Expected loss rate Total book value Loss allowance December31,2020 Expected loss rate Total book value Loss allowance September30,2020 Expected loss rate Total book value Loss allowance |
Up to 90 days pastdue |
91 to180 days pastdue |
181 to 360 days pastdue |
Up to 361 days |
Total 1,731,430 $ 204 $ Total |
|---|---|---|---|---|---|
| 0.01%~0.03% 1,731,430 $ 204 $ Up to 90 days pastdue |
15%~20% - $ - $ 91 to 180 days pastdue |
30%~40% - $ - $ 181 to 360 days pastdue |
100% - $ - $ Up to 361 days |
||
| 0.02%~0.03% 1,278,063 $ 266 $ Up to 90 days pastdue |
15%~20% - $ - $ 91 to 180 days pastdue |
30%~40% - $ - $ 181 to 360 days pastdue |
100% - $ - $ Up to 361 days |
1,278,063 $ 266 $ Total |
|
| 0.02%~0.03% 1,047,585 $ 220 $ |
15%~20% - $ - $ |
30%~40% - $ - $ |
100% - $ - $ |
1,047,585 $ 220 $ |
viii. Movements in relation to the Group applying the simplified approach to provide loss allowance for contract assets and accounts receivable are as follows:
| At January 1 Reversal of impairment loss Effect of foreign exchange At September 30 At January 1 Reversal of impairment loss Write-offs Effect of foreign exchange At September 30 |
|||
|---|---|---|---|
| Contract assets | |||
| Contract assets | |||
| - $ - - - - $ |
~55~
-
ix. The Group’s recorded financial assets at amortized cost include time deposits with contract period over three months, restricted bank deposits and structured deposits of guaranteed floating revenue of financial assets at fair value through profit or loss. Because of the low credit risk, expected credit losses for the period are measured through a loss allowance at an amount equal to the 12-month expected credit losses. There is no significant provision for the losses.
-
(c) Liquidity risk
-
i. Cash flow forecasting is performed in the operating entities of the Group and aggregated by Group treasury. Group treasury monitors rolling forecasts of the Group’s liquidity requirements to ensure it has sufficient cash to meet operational needs while maintaining sufficient headroom on its undrawn committed borrowing facilities. Such forecasting takes into consideration the Group’s debt financing plans, and compliance with internal balance sheet ratio targets.
-
ii. Surplus cash held by the operating entities over and above the balance required for working capital management are transferred to the Group treasury. Group treasury invests surplus cash in interest bearing current accounts, time deposits and marketable securities, choosing instruments with appropriate maturities or sufficient liquidity to provide sufficient headroom as determined by the above-mentioned forecasts.
iii.The Group has the following undrawn borrowing facilities:
| 0 Fixed rate: Expiring within one year Expiring beyond one year |
September30,2021 2,338,746 $ - 2,338,746 $ |
December31,2020 2,814,256 $ 950,000 3,764,256 $ |
September30,2020 |
|---|---|---|---|
| 2,674,766 $ 1,200,000 |
|||
| 3,874,766 $ |
- iv.The table below analyses the Group’s non-derivative financial liabilities into relevant maturity groupings based on the remaining period at the balance sheet date to the contractual maturity date for non-derivative financial liabilities. The amounts disclosed in the table are the contractual undiscounted cash flows.
| he table are the contractual undiscounted | cash flows. | |
|---|---|---|
| September 30, 2021 Non-derivative financial liabilities: Short-term borrowings Short-term notes and bills payable Accounts payable Other payables Lease liabilities Guarantee deposits received |
Less than 1year 2,510,000 $ 399,939 1,747,256 607,376 10,805 - |
Over 1year |
| - $ - - - 114,091 22,903 |
~56~
| December 31, 2020 Non-derivative financial liabilities: Short-term borrowings Short-term notes and bills payable Accounts payable Other payables Lease liabilities Long-term borrowings (including current portion) Guarantee deposits received September 30, 2020 Non-derivative financial liabilities: Short-term borrowings Accounts payable Other payables Lease liabilities Guarantee deposits received |
Lessthan 1year 2,330,000 $ 299,798 1,296,475 485,953 10,443 250,000 - Lessthan 1year 2,730,000 $ 1,013,430 548,621 8,316 - |
Over 1year |
|---|---|---|
| - $ - - - 111,661 - 26,480 Over 1year |
||
| - $ - - 107,901 30,532 |
(3) Fair value estimation
-
A. The different levels that the inputs to valuation techniques are used to measure fair value of financial and non-financial instruments have been defined as follows:
-
Level 1: Quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date. A market is regarded as active where a market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis.
-
Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
-
Level 3: Unobservable inputs for the asset or liability. The fair value of the Group’s investment in equity investment without active market, structured deposits and investment property are included in Level 3.
-
B. Fair value information of investment property at cost is provided in Note 6(9).
-
C. Financial instruments was not measured at fair value, including the carrying amounts of cash and cash equivalents, financial assets at amortized cost, accounts receivable, other receivables, deposits paid, long-term borrowings, short-term borrowings, short-term bills payable, notes payable, accounts payable, other payables, deposit received and lease liabilities are approximate to their fair values.
~57~
-
D. The related information of financial and non-financial instruments measured at fair value by level on the basis of the nature, characteristics and risks of the assets and liabilities are as follows:
-
(a) The related information of natures of the assets is as follows:
| September 30, 2021 | Level 1 | Level 2 | Level 3 | Total | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Recurring fair value | ||||||||||
| measurements | ||||||||||
| Financial assets at fair | ||||||||||
| value through profit | ||||||||||
| or loss | ||||||||||
| Unlisted stocks | $ | - |
$ | - |
$ | 68,441 |
$ | 68,441 |
||
| Financial assets at fair | ||||||||||
| value through other | ||||||||||
| comprehensive income | ||||||||||
| Unlisted stocks | - | - | 122,693 | 122,693 | ||||||
| $ | - |
$ | - |
$ | 191,134 |
$ | 191,134 |
|||
| December 31, 2020 | Level 1 | Level 2 | Level3 | Total | ||||||
| Assets | ||||||||||
| Recurring fair value | ||||||||||
| measurements | ||||||||||
| Financial assets at fair | ||||||||||
| value through profit | ||||||||||
| or loss | ||||||||||
| Structured deposits | $ | - |
$ | - |
$ | 349,664 |
$ | 349,664 |
||
| Unlisted stocks | - | - | 48,229 | 48,229 | ||||||
| Financial assets at fair | ||||||||||
| value through other | ||||||||||
| comprehensive income | ||||||||||
| Unlisted stocks | - | - | 43,130 | 43,130 | ||||||
| $ | - |
$ | - |
$ | 441,023 | $ | 441,023 |
~58~
| September 30, 2020 Assets Recurring fair value measurements Financial assets at fair value through profit or loss Unlisted stocks Financial assets at fair value through other comprehensive income Unlisted stocks |
Level 1 - $ - - $ |
Level 2 - $ - - $ |
Level3 48,076 $ 45,544 93,620 $ |
Total |
|---|---|---|---|---|
| 48,076 $ 45,544 |
||||
| 93,620 $ |
-
(b) The methods and assumptions the Group used to measure fair value are as follows:
- i. Except for financial instruments with active markets, the fair value of other financial instruments is measured by using valuation techniques. The fair value of financial instruments measured by using valuation techniques can be referred to current fair value of instruments with similar terms and characteristics in substance, discounted cash flow method or other valuation methods, including calculated by applying model using market information available at the consolidated balance sheet date.
-
ii. The output of valuation model is an estimated value and the valuation technique may not be able to capture all relevant factors of the Group’s financial and non-financial instruments. Therefore, the estimated value derived using valuation model is adjusted accordingly with additional inputs.
-
E. For the nine-month periods ended September 30, 2021 and 2020, there was no transfer between Level 1 and Level 2.
-
F. The following chart is the movement of Level 3 for the nine-month periods ended September 30, 2021 and 2020:
| 2021 | 2020 | |||
|---|---|---|---|---|
| At January 1 | $ | 441,023 |
$ | 90,800 |
| Purchases in the period | 238,100 | - | ||
| Gains recognised in profit or loss | 27,931 | 7,920 | ||
| Gains (losses) recognised in other comprehensive | 1,013 | ( | 440) |
|
| Sold in the period | ( | 509,288) |
- | |
| Proceeds from capital reduction in the period | ( | 3,056) |
( | 4,364) |
| Effect of exchange rate changes | ( | 4,589) | ( | 296) |
| At September 30 | $ | 191,134 |
$ | 93,620 |
~59~
-
G. For the nine-month periods ended September 30, 2021 and 2020, there was no transfer of Level 3.
-
H. Accounting Department segment is in charge of valuation procedures for fair value measurements being categorised within Level 3, which is to verify independent fair value of financial instruments. Such assessment is to ensure the valuation results are reasonable by applying independent information to make results close to current market conditions, confirming the resource of information is independent, reliable and in line with other resources and represented as the exercisable price, and frequently calibrating valuation model, performing back-testing, updating inputs used to the valuation model and making any other necessary adjustments to the fair value.
-
I. The following is the qualitative information of significant unobservable inputs and sensitivity analysis of changes in significant unobservable inputs to valuation model used in Level 3 fair value measurement:
| value measurement: | ||||
|---|---|---|---|---|
| Financial assets at fair value through profit or loss Unlisted shares Financial assets at fair value through other comprehensive income Unlisted shares |
Fair value at September 30,2021 |
Valuation technique |
Significant unobservable input |
Relationship of inputs to fair value |
| $ 68,441 122,693 |
Market comparable companies Net asset value |
Price to earnings ratio multiple, price to book ratio multiple,discount for lack of marketability, control premium Not applicable |
The higher the multiple and control premium, the higher the fair value Not applicable |
~60~
| Financial assets at fair value through profit or loss Structured deposit Unlisted shares Financial assets at fair value through other comprehensive income Unlisted shares Financial assets at fair value through profit or loss Unlisted shares Financial assets at fair value through other comprehensive income Unlisted shares |
Fair value at December 31,2020 |
Valuation technique |
Significant unobservable input |
Relationship of inputs to fair value |
|---|---|---|---|---|
| 349,664 $ 48,229 43,130 Fair value at September 30,2020 |
Depends on individual contract Market comparable companies Net asset value Valuation technique |
Depends on individual contract Price to earnings ratio multiple, price to book ratio multiple,discount for lack of marketability, control premium Not applicable Significant unobservableinput |
Depends on individual contract The higher the multiple and control premium, the higher the fair value Not applicable Relationship of inputs to fairvalue |
|
| 48,076 $ 45,544 |
Market comparable companies Net asset value |
Price to earnings ratio multiple, price to book ratio multiple,discount for lack of marketability, control premium Not applicable |
The higher the multiple and control premium, the higher the fair value Not applicable |
~61~
- ’ (4) The impact of the COVID 19 pandemic to the Group s operation
In response to the third-level epidemic prevention alert of COVID-19 implemented in May, 2021, the Group has adjusted the work style of employees, strengthened disinfection and control of personnel entry and exit measures for operating entities in Taiwan. The Group assessed that the COVID-19 pandemic had no significant impact to its overall operating activities and financial statements as of September 30, 2021.
13. SUPPLEMENTARY DISCLOSURES
(1) Significant transactions information
-
A. Loans to others: Please refer to table 1.
-
B. Provision of endorsements and guarantees to others: None.
-
C. Holding of marketable securities at the end of the period (not including subsidiaries, associates and joint ventures) : Please refer to table 2.
-
D. Acquisition or sale of the same security with the accumulated cost exceeding NT$300 million or 20% of the Company’s paid-in capital: None.
-
E. Acquisition of real estate reaching NT$300 million or 20% of paid-in capital or more: None.
-
F. Disposal of real estate reaching NT$300 million or 20% of paid-in capital or more: None.
-
G. Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paidin capital or more: Please refer to table 3.
-
H. Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more: Please refer to table 4.
-
I. Trading in derivative financial instruments undertaken during the reporting periods: None.
-
J. Significant inter-company transactions during the reporting periods: Please refer to table 5.
(2) Information on investees
Names, locations and other information of investee companies (not including investees in Mainland China): Please refer to table 6.
(3) Information on investments in Mainland China
-
A. The related information of investments in Mainland China: Please refer to table 7.
-
B. Significant transactions, either directly or indirectly through a third area, with investee companies in the Mainland Area:
-
For the significant purchases, sales, accounts payable and accounts receivable transactions between the Company and the investee companies in Mainland China through its subsidiaries, please refer to table 3 ~ table 5.
(4) Major shareholders information
Please refer to table 8.
~62~
14. SEGMENT INFORMATION
(1) General information
The Group mainly operates in one segment. The Chief Operating Decision-Maker reviews the Group’s reporting to assess performance and allocate resources. The Group mainly has a single reportable segment.
(2) Measurement of segment information
The Group evaluates performance based on profit or loss by using sales revenue and operation profit measurements. The accounting policies of the Group's operating segments are the same as the significant accounting policies summarized in Note 4.
(3) Information about segment profit or loss, assets and liabilities
The Group has a single reportable segment. The revenue from external customers, the related gain or loss, and the assets correspond with the consolidated revenue, consolidated operating income, and consolidated assets.
(4) Reconciliation for segment income (loss)
The amounts provided to the Chief Operating Decision-Maker with respect to department assets, liabilities and profit are measured in a manner consistent with that of the financial statements.
~63~
Altek Corporation and subsidiaries Loans to other For the nine-month period ended September 30, 2021
| No. Table 1 |
Creditor | Borrower | General ledger account |
Is a related party |
Maximum outstanding balance during nine-month period the September 30, 2021 |
Balance at September 30, 2021 |
Actual amount drawn down |
Interest rate |
Nature of loan |
Amount of transactions with the borrower |
Reason term financing |
Allowance for doubtful accounts |
Coll | ateral | Limit on loans granted to a singleparty Expressed in th (Except as othe |
Ceiling on total loans granted ousands of NTD rwise indicated) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Item | Value | |||||||||||||||
| 1 | Altek Semiconductor (Cayman) Co., Ltd. |
Altek Semiconductor Corporation |
Other receivables- related party |
Yes | 142,675 $ |
139,250 $ |
- $ |
0% | Reason for short-term financing |
- $ |
Operational need |
- $ |
Promissory note |
139,250 $ |
1,087,778 $ |
1,087,778 $ |
Note 1: The ”Procedure for Provision of Loans” policy for loans granted by Altek Semiconductor (Cayman) Co.,Ltd. is as follows: the ceiling on total loans is 100% of the net assets value of lender. For the short-term financing, the ceiling on loans is 40% of the net assets value of lender.
Note 2: If the amount of NTD in this Note relates to foreign currencies, it is converted to NTD at the exchange rate at the end of the financial reporting period.
Table 1
Altek Corporation and subsidiaries
Holding of marketable securities at the end of the period (not including subsidiaries, associates and joint ventures)
September 30, 2021
Table 2
Expressed in thousands of NTD (Except as otherwise indicated)
| Securitiesheld by | Marketable securities | Relationship with the securitiesissuer |
General ledgeraccount |
As ofSeptember30,2021 | As ofSeptember30,2021 | ||
|---|---|---|---|---|---|---|---|
| Numberofshares | Bookvalue | Ownership (%) | Fairvalue | ||||
| Altek Corporation " Altek (Kunshan) Co., Ltd. Altek EMS (Kunshan) Co., Ltd. |
Gianta Co., Ltd. - Common stock Hua-chuang Automobile Information Technical Center Co., Ltd. - Common stock CPEC Huachuang Private Equity (Kunshan) Enterprise (Limited Partnership) Aimore Acoustics Incorporation |
The Comyany is director of the investee None None The Comyany is director of the investee |
Financial assets at fair value through profit or loss - non-current Financial assets measured at fair value through other comprehensive income - non-current Financial assets measured at fair value through other comprehensive income - non-current Financial assets measured at fair value through other comprehensive income - non-current |
762,876 2 N/A N/A |
68,441 $ - 36,808 85,885 |
14.55% 0.00% (Note 1) (Note 2) |
68,441 $ - 36,808 85,885 |
Note 1: 1% of CPEC Huachuang Private Equity (Kunshan) Enterprise (Limited Partnership)’s capital contribution. Note 2: 12.5% of Aimore Acoustics Incorporations’s capital contribution.
Table 2
Altek Corporation and subsidiaries
Purchases or sales of goods from or to related parties reaching NT$100 million or 20% of paid-in capital or more
For the nine-month period ended September 30, 2021
| Table 3 Purchaser/seller |
Counterparty | Relationship with the counterparty |
Transaction | Transaction | Differences in transaction terms compared to third party transactions |
Differences in transaction terms compared to third party transactions |
Notes/accounts receivable(payable) Expressed in thousands of NTD (Except as otherwise indicated) |
Notes/accounts receivable(payable) Expressed in thousands of NTD (Except as otherwise indicated) |
||
|---|---|---|---|---|---|---|---|---|---|---|
| Purchases (sales) |
Amount | Percentage of total purchases (sales) |
Credit term | Unitprice | Credit term | Balance | Percentage of total notes/accounts receivable(payable) |
|||
| Altek Corporation Altek International Trading Co., Ltd. Altek Biotechnology Corporation Altek Medical Holding (Cayman) Co., Ltd. Taiwan Branch Altek (Kunshan) Co., Ltd. |
Altek International Trading Co., Ltd. Altek (Kunshan) Co., Ltd. Altek International Trading Co., Ltd. " " |
Parent company The same ultimate parent company " " " |
Purchases Purchases Purchases Purchases Purchases |
3,068,491 $ 5,144,623 1,336,904 373,104 311,132 |
90% 100% 100% 100% 6% |
Net 120 days Net 75 days " " " |
Approximately the same price with third parties " " " " |
Note " " " " |
1,217,279) ($ 1,415,606) ( 323,092) ( 99,542) ( - |
94% 100% 99% 100% 0% |
Note: The payment term with third parties was net 60~120 days.
Table 3
Altek Corporation and subsidiaries
Receivables from related parties reaching NT$100 million or 20% of paid-in capital or more
September 30, 2021
| Table 4 Creditor |
Counterparty | Relationship with the counterparty |
Balance as at September 30, 2021 |
Turnover rate | Overdue receivables | Overdue receivables | Amount collected subsequent to the balance sheet date Allowance for doubtful accounts Expressed in thousands of NTD (Except as otherwise indicated) |
Amount collected subsequent to the balance sheet date Allowance for doubtful accounts Expressed in thousands of NTD (Except as otherwise indicated) |
|---|---|---|---|---|---|---|---|---|
| Amount | Action taken | |||||||
| Altek International Trading Co., Ltd. " Altek (Kunshan) Co., Ltd. |
Altek Corporation Altek Biotechnology Corporation Altek International Trading Co., Ltd. |
Parent company The same ultimate parent company The same ultimate parent company |
1,217,279 $ 323,092 1,415,606 |
3.91 4.71 5.10 |
- $ - - |
N/A N/A N/A |
322,179 $ 196,927 558,529 |
- $ - - |
Table 4
Altek Corporation and subsidiaries
Table 5
Significant inter-company transactions during the reporting periods
For the nine-month period ended September 30, 2021
Expressed in thousands of NTD
(Except as otherwise indicated)
| Companyname | Counterparty | Relationship (Note1) |
Transaction | |||
|---|---|---|---|---|---|---|
| General ledgeraccount | Amount | Transactionterms | Percentage of consolidated total operating revenues ortotalassets (Note2) |
|||
| Altek Corporation " Altek International Trading Co., Ltd. " Altek Semiconductor Corporation " " Altek Biotechnology Corporation " Altek Medical Holding (Cayman) Co., Ltd. Taiwan Branch " Altek (Kunshan) Co., Ltd. Altek Optical Technology (Kunshan) Co., Ltd " |
Altek International Trading Co., Ltd. " Altek (Kunshan) Co., Ltd. " Altek International Trading Co., Ltd. " Altek Corporation Altek International Trading Co., Ltd. " " " " Altek (Kunshan) Co., Ltd. " |
(1) (1) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) (3) |
Purchases Accounts payable Purchases Accounts payable Purchases Accounts payable Purchases Purchases Accounts payable Purchases Accounts payable Purchases Purchases Accounts payable |
3,068,491 $ 1,217,279 5,144,623 1,415,606 18,562 19,538 12,007 1,336,904 323,092 373,104 99,542 311,132 12,537 13,779 |
Net 120 days " Net 75 days " Net 120 days " Net 75 days " " " " " " " |
45% 8% 76% 9% 0% 0% 0% 20% 2% 6% 1% 5% 0% 0% |
Note 1: Relationship between transaction and counterparty is classified into the following categories:
(1) Parent company to subsidiary.
-
(2) Subsidiary to parent company.
-
(3) Subsidiary to subsidiary.
Note 2: Regarding percentage of transaction amount to consolidated total operating revenues or total assets, it is computed based on period-end balance of transaction to consolidated total assets for balance sheet accounts and based on accumulated transaction amount for the period to consolidated total operating revenues for income statement accounts.
Note 3: The Company may decide to disclose or not to disclose transaction details in this table based on the Materiality Principle.
Table 5
Altek Corporation and subsidiaries
Information on investees
Table 6
Expressed in thousands of NTD (Except as otherwise indicated)
For the nine-month period ended September 30, 2021
| Investor | Investee | Location | Main business activities | Initial invest | ment amount | Shares he | ld as at September | 30,2021 | Net profit (loss) of the investee for the nine-month period ended September 30,2021 |
Investment income(loss) recognised by the Company for the nine-month period ended September 30,2021 |
Footnote |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance as at September 30, 2021 |
Balance as at December 31, 2020 |
Number of shares | Ownership (%) | Book value | |||||||
| Altek Corporation " " " Altek International Investment Co., Ltd. " " " Altek International Holding (BVI) Co, Ltd. Altek Investment Corporation Altek Semiconductor (Cayman) Co., Ltd. Altek Medical Holding (Cayman) Co., Ltd. Altek Medical Holding (Cayman) Co., Ltd. |
Altek International Investment Co., Ltd. Altek Japan Corporation Altek International Holding (BVI) Co, Ltd. Altek Investment Corporation Altek Lab Inc. Altek Semiconductor (Cayman) Co., Ltd. Altek Optical Technology (Cayman) Co., Ltd. Altek International Trading Co., Ltd. Altek Medical Holding (Cayman) Co. ,Ltd. Ptek Corporation Altek Semiconductor Corporation Altek Biotechnology Corporation Altek Medical (HongKong) Limited |
British Virgin Islands Japan British Virgin Islands Republic of China U.S.A. Cayman Islands Cayman Islands Republic of Seychelles Cayman Islands Republic of China Republic of China Republic of China HongKong |
Investment Sale of optical optical instruments Investment Investment Design service Investment Investment Intercompany transactions Investment and general business operations Product development and design Research design and sales of ASIC Research and development, manufacture and sales of medical electronic equipments Investment |
2,882,512 $ 2,869 415,376 100,000 102,481 171,200 368,901 278,500 311,398 3,000 350,000 115,376 33,420 |
2,882,512 $ 2,869 415,376 100,000 102,481 171,200 311,920 278,500 415,376 - 350,000 415,376 - |
87,769,559 1,000 12,865,921 10,000,000 11,311,875 20,000,000 13,246,000 10,000,000 45,063,684 300,000 35,000,000 10,100,000 N/A |
100 100 100 100 100 50 100 100 82.18 100 100 100 100 |
8,430,211 $ 10,451 1,010,021 99,868 58,786 581,020 83,477 235,599 662,747 2,996 326,023 494,486 33,127 |
212,882 $ 350 134,202 53) ( 994 68,484 20,975 12,496) ( 157,636 4) ( 74,497 37,505 170) ( |
210,188 $ 350 134,202 53) ( 994 34,437 20,975 12,496) ( 134,182 4) ( 37,248 30,886 170) ( |
Note 1 Note 2 Note 3 Note 2 Note 2 |
Note 1: The difference between the profit or loss of the investee for the current period and the investment profit or loss recognized in the current period is the unrealized profit and loss adjustments for counterparty transactions between subsidiaries. Note 2: Altek Biotechnology Holding (Cayman) Co., Ltd. changed its name to Altek Medical Holding (Cayman) Co., Ltd. Since June 8, 2021. Note 3: Ptek Corporation changed its Chinese name on August 11, 2021.
Table 6
Altek Corporation and subsidiaries
Information on investments in Mainland China
Table 7
For the nine-month period ended September 30, 2021
Expressed in thousands of NTD (Except as otherwise indicated)
| Investee in MainlandChina | Main business activities | Paid-in capital | Investment method (Note 1) |
Accumulated amount of remittance from Taiwan to Mainland China as of January1,2021 |
Amount remitted from Taiwan to Mainland China/Amount remitted back to Taiwan for the nine-month period ended September30,2021 |
Accumulated amount of remittance from Taiwan toMainland China as of September30,2021 |
Net profit (loss) of investee for the nine-month period endedSeptember30,2021 |
Ownership held by the Company (direct or indirect) |
Investment income (loss) recognised by the Company for the nine-month period ended September 30, 2021 (Note 4) |
Accumulated amount of investment income remitted back to Taiwan as of September30,2021 Book value of investments in Mainland China as of September30,2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Remitted to Mainland China Remitted back to Taiwan |
||||||||||
| Altek (Kunshan) Co., Ltd. (Note 2) Altek EMS (Kunshan) Co., Ltd. (Note 3) Altek Trading (Shanghai) Limited Altek Precision (Kunshan) Co., Ltd. Altek Optical Technology (Kunshan) Co., Ltd. Altek Semiconductor (Shanghai) Co., Ltd. Altek Medical (Shanghai) Limited Altek Medical (Kunshan) Limited Note 1: Investment method (1)Directly invest in |
Manufacture and sale of digital still cameras and its accessories Manufacture and sale of related engineering services Wholesale, import and export of digital cameras, digital video cameras and their associated accessories Design, manufacture and sales of digital camera parts Manufacture and sales of photo electron device, optical instrument, camera and equipment Research design and sales of imaging technologies, electronic software and hardware Sales of medical electronic equipment Manufacture and sale of medical electronic equipment s are classified into the following th a company in Mainland China. |
1,381,360 $ 139,250 236,725 384,330 389,900 41,775 27,850 25,766 ree categories; fill i |
2 2 2 2 2 2 2 2 n the number o |
1,253,250 $ - $ - $ 252,962 - - 236,725 - - 384,330 - - 311,920 58,485 - - - - - - - - - - f category each case belongs to: |
1,253,250 $ 252,962 236,735 384,330 370,405 - - - |
162,104 $ 11,046 4,590 1,562 27,970 6,504) ( 170) ( 12) ( |
100 100 100 100 75 50 82.18 82.18 |
162,104 $ 11,046 4,590 1,562 20,977 3,252) ( 140) ( 10) ( |
4,349,635 $ - $ 782,984 - 308,785 - 150,235 - 83,474 - 109,017 - 27,558 - 25,753 - |
(2)Through investing in an existing company in the third area,which then investeed in the investee in Mainland China. (3)Others. Note 2: Including retained earnings capitalized of US$4,600 (In thousand of US dollars). Note 3: Including retained earnings capitalized of US$3,600 (In thousand of US dollars). Note 4:The basic explanation of investment profit and loss recognition is as follows: (1)Altek (Kunshan) Co., Ltd. are reviewed by the R.O.C. parent company’s independent auditors.
(2)Other companies are self-prepared financial statements.
| Companyname | Accumulated amount of remittance from Taiwan to MainlandChina as ofSeptember30,2021 |
Investment amount approved by the Investment Commission of the Ministryof Economic Affairs(MOEA) |
Ceiling on investments in Mainland China imposed bythe InvestmentCommission of MOEA |
|---|---|---|---|
| Altek Corporation | $2,497,672 | $2,800,369 | $5,087,580 |
Table 7
Altek Corporation and subsidiaries Information of major shareholders September 30, 2021
Table 8
| Name of major shareholders | Shares | Shares |
|---|---|---|
| Number of shares held | Holding percentage | |
| Yitsang International Co., Ltd. | 14,360,100 | 5.14% |
Table 8